The effects of an acute bout of whole-body vibration on pulse wave velocity in individuals with SCI by Leber, Ben
The Effects of an Acute Bout of Whole-Body Vibration on Pulse 
Wave Velocity in Individuals with SCI 
Ben Leber, BSc. Kinesiology 
Submitted in partial fulfillment of the requirements for the degree 
Master of Science in Applied Health Sciences 
(Kinesiology) 
Supervisor: David Ditor, PhD 
Faculty of Applied Health Sciences 
Brock University 
St. Catharines, ON. 
Ben Leber © September, 2010 
Abstract 
Cardiovascular disease is a leading cause of mortality in the spinal cord injured (SCI) 
population. Reduced arterial compliance is a cardiovascular risk factor and whole body 
vibration (WBV) has been shown to improve arterial compliance in able-bodied 
individuals. The study investigated the effect of an acute session ofWBV on arterial 
compliance as measured by pulse wave velocity (PWV). On separate days, arm, leg and 
aortic PWV were measured pre- and post- a 45 minute session of passive stance (PS) and 
WBV. The WBV was intermittent with a set frequency of 45Hz and amplitude of O.6mm. 
There was no condition by time effect when comparing PWV after WBV and PS. 
Following WBV, aortic (928.6±127.7 vs. 901.1±96.6cm/sec), leg (1035.2±113.8 
vs.l099.8±114.2cm/sec) and arm PWV (1118.9±119.8 vs. 1181.1±124.4cm/s) did not 
change. As such, WBV did not reduce arterial compliance, however future research with 
protocol modifications is recommended. 
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Chapter 1: Introduction 
Sustaining a spinal cord injury (SCI) is a life-altering and devastating event. The 
prevalence of individuals living with a SCI in North America is approximately 1-2% of 
the total population. The main cause of SCI is motor vehicle accidents followed by falls, 
sport injuries and violence (DeVivo et al., 1999; Pickett et aI., 2006). The average 
lifetime cost for individuals living in the United States with paraplegia and an age of 
injury of 25 years is $428,000, and the average lifetime cost for individuals living with 
tetraplegia with an age of onset of25 years is $1.25 million (Gondim et al., 2004). 
With SCI, the most obvious life altering effect is the individual's loss of mobility. 
However, after sustaining a SCI there are many life-threatening secondary health 
consequences in both the acute and long-term stages of the disability. Acutely, pulmonary 
complications are the most common cause of death, while in the long-term, respiratory 
and cardiovascular complications account for half of all deaths (DeVivo et al., 1999). 
Cardiovascular disease (CVD) is becoming a leading cause of mortality among 
the SCI population and the morbidity associated with CVD is prominent at a younger age 
(Krassioukov et al., 2003). With an increased survival rate within the SCI population, 
CVD will continue to increase and account for greater morbidity and mortality. Along 
with the altered autonomic function, the primary risk factors for CVD are the sedentary 
lifestyle and lack of physical activity associated with the injury (Groah et al., 2001), 
which in turn lead to an increased risk of type 2 diabetes (Myers et al., 2007), 
dyslipaedemia (Bauman et aI., 1999; Jones et aI., 2004; Myers et al., 2007), 
intramuscular fat (Bauman et aI., 1999; Elder et al., 2004), and greater platelet 
aggregation (Kahn et al., 2001). 
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Another significant risk factor for CVD is the reduction of arterial compliance; or 
the increase in the stiffness of the blood vessels. Diminished arterial compliance is 
associated with cardiovascular and coronary arterial events such as myocardial infarction 
(Nakae et al., 2008), atherosclerosis (Arnett et al., 1994), and an increase in systolic 
blood pressure (Arnett et al., 1994; Hermeling et al., 2007). As well, arterial stiffness 
promotes ventricular wall remodeling and subsequent load-dependent alterations in 
diastolic function (Abhayaratna et al., 2008). Arterial compliance is, in part, a function of 
the change in the intimal-media layer of the arterial endothelium. A reduced ratio of 
elastin to collagen andlor an increased smooth muscle tone results in decreased 
compliance of the vessel . A lower degree of arterial compliance is associated with the 
cardiovascular risk factors of age, gender, lipoprotein abnormalities and diabetes (Arnett 
et al., 1994). 
Measures of arterial compliance are conducted by estimating the artery's capacity 
to expand and contract with cardiac pulsation and relaxation. Pulse wave velocity (PWV) 
refers to the speed of the blood pressure wave as it travels along a vessel, and the 
measurement of this velocity can be used as a non-invasive diagnostic tool for the 
estimate of arterial compliance. Specifically, PWV is the measurement of the speed of the 
blood pressure wave as it travels between two sets of anatomical points within the arterial 
system (Miyatani et al., 2009). A faster speed of the blood pressure wave signifies a 
stiffer and less compliant blood vessel. The use of PWV as a non-invasive imaging 
technique may aid in quantifying the risk of CVD and in fact, this measurement 
technique, has been shown to predict cardiovascular outcomes independent of traditional 
risk factors (Abhayaratna et al., 2008). 
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There are two measurement strategies used when evaluating PWV. The first 
concerns 'central' PWV which measures long arterial trajectories and is measured 
between the carotid and femoral arteries (Hermeling et al., 2007). The second method 
concerns 'peripheral' PWV. In this method, the blood pressure wave is measured within a 
small arterial trajectory, for example from the femoral artery to the posterior tibial artery 
(Hermeling et al., 2007). Central PWV, measured along the aortic and aortoiliac 
pathway, is most clinically relevant because the aorta and its first branches are 
responsible for most of the pathophysiological effects of reduced arterial compliance 
(Boutouyrie et al., 2002). 
One study known to date has investigated the use of PWV to assess arterial 
compliance for individuals living with SCI. Miyatani et al. (2009) compared a cohort of 
12 individuals with SCI to age, gender, height and weight matched non-SCI controls. The 
study found that mean aortic (central) PWV was greater in the SCI group than the control 
group (1274±369cm/s to 948±110cm/s), suggesting an increased risk for CVD in the SCI 
group. 
Pulse wave velocity has been shown to be a valid and reliable estimate of arterial 
stiffness in able-bodied individuals. Lehmann et al. (1992) determined the coefficient of 
variation (CV) of intra- (8.5%) and inter- (9.4%) observer repeatability to be very low for 
aortic PWV in healthy individuals. In addition, studies by Lee et al. (2009) and Naidu et 
al. (2005) used intraclass correlations to demonstrate significant high correlations 
(p<0.05) for intra- and inter-observer reliability for aortic PWV measurements. However, 
Frimodt-Moller et aI, (2008) found a significant intra-observer difference for aortic PWV 
despite no significant inter-observer difference. There was also no difference found for 
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intra- or inter-observer brachial PWV (Frimodt-Moller et al., 2008). Therefore, despite 
the demonstrated repeatability ofPWV, it may still be necessary to conduct inter- and 
intra-observer repeatability calculations to ensure proper interpretation of results. As it 
has never been evaluated in the SCI population, future studies should determine the inter-
and intra-observer reliability for PWV in this population. 
Arterial compliance has been studied in conjunction with exercise protocols 
primarily focusing on aerobic and resistance training (Heffernan et al., 2007; Otsuki et 
al., 2007). These studies demonstrated that after endurance training, arterial compliance 
was increased while after strength training, arterial compliance was decreased. Similarly, 
Jae and colleagues (2008) found that individuals living with paraplegia who regularly 
participated in aerobic exercise had no difference in carotid mean intima thickness 
(another index of arterial compliance) when compared to able-bodied individuals. 
Likewise, normotensive paraplegics who did not participate in regular exercise, 
demonstrated decreased arterial compliance, as determined by augmentation index, when 
compared to able-bodied controls (Yim et al., 1993). 
Exercise is an important component of what is considered to be a healthy lifestyle 
and aerobic exercise has been shown to increase arterial compliance and improve 
cardiovascular health (Tanaka et al., 2000; Thijssen et al., 2007). Unfortunately, exercise 
can be difficult for those living with a SCI and as such, this population is living within 
the low end of the physical activity spectrum (Elder et al., 2004). The most common 
modalities of exercise which significantly affect cardiovascular outcomes for individuals 
with a SCI include arm ergometry (Cowell et al., 1986; Davis et al., 1981; Franklin, 
1985), body-weight supported treadmill training (BWSTT) (Ditor et aI., 2005) and 
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functional electrical stimulation (FES) (Mutton et al., 1997). However, these exercise 
modalities have many disadvantages. Arm ergometry may only be beneficial for those 
with higher level functioning, thus excluding many individuals living with tetraplegia 
while BWSTT is very costly and labour intensive. FES carries the small but notable risks 
of pain, autonomic dysreflexia, and bone fractures and, cannot be used in individuals with 
lower motor neuron injuries. 
Whole body vibration (WBV) may be a unique exercise solution for individuals 
with SCI. When standing on a platform which oscillates vertically or in a sinusoidal 
direction, the vibrations are transmitted through the body eliciting a stretch reflex in the 
muscles. This neuromuscular response is known as the 'tonic vibration reflex'. This 
reflex is able to cause an increase in recruitment of motor units through activation of 
muscle spindle and polysynaptic pathways (Seidel, 1988). As well, the effect of the 
vibration causing a mechanical shearing of the blood vessels is thought to result in vessel 
deformation and release of nitric oxide which causes vasodilatation. This form of 
exercise shows promise for vulnerable populations who have a limited ability to perform 
voluntary exercise. 
In the able-bodied population, one study hasjnvestigated the direct effect of 
WBV on arterial compliance using PWV as the experimental measure. Otsuki and 
colleagues (2008) assessed arterial compliance measuring brachial-ankle PWV in 10 
healthy men, before as well as 20, 40 and 60 minutes after acute bouts ofWBV. 
Vibration was set at 26Hz and a 2-4mm amplitude. Vibration occurred for 10 sets of 60 
seconds on, 60 seconds off. The results showed that in the WBV group, brachial-ankle 
PWV was significantly reduced at 20 and 40 minutes but not 60 minutes after the trial 
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without any significant decrease in blood pressure. The mechanisms underlying the 
exercise-induced acute reduction of arterial compliance is unknown but may be related to 
mechanical stimuli, which as mentioned, may elicit vasodilatation via the release of nitric 
oxide (Otsuki et al., 2008). 
The results of the studies mentioned show a great promise for the SCI population. 
Because individuals with SCI typically adopt a sedentary lifestyle, they are at increased 
risk for CVD and have an increased morbidity at a younger age compared to the able-
bodied population. It is known that aerobic exercise improves cardiovascular fitness. 
However people with SCI, particularly individuals living with tetraplegia, face challenges 
finding effective exercise modalities. The modalities currently available (arm ergometry, 
FES, BWSTT) while beneficial to some individuals have side effects and/or 
complications and pose practical administrative problems. The use of WBV has been 
shown to augment arterial compliance in able-bodied individuals, who are either in good 
I 
health or suffer from disease. It is possible that WBV will be an effective form of I 
exercise to increase the arterial compliance in individuals with SCI and therefore improve 
their cardiovascular health. 
This study will evaluate the change in arterial compliance following acute WBV 
exercise using the non-invasive measurement ofPWV. If an increase in arterial 
compliance is observed, WBV may be further studied and protocols designed to provide a 
safe, practical and easily applied form of CVD risk reduction for individuals with SCI 
who have difficulty with traditional exercise. In addition, this study will evaluate the 
inter- and intra-observer reliability for PWV in individuals with SCI as it has previously 
never been done. 
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It is postulated that a reduction in arterial stiffness will improve cardiovascular 
health and reduce CVD morbidity, thus improving the quality of life and reducing the 
medical costs related to living with SCI. Reduced arterial compliance is associated with 
increased risk for CVD and coronary artery disease and therefore increasing compliance 
would ultimately reduce the risk and the associated morbidity and mortality. 
1.1 Hypotheses 
The hypotheses of the current study are: i) each participant will show a reduction 
in PWV after an acute bout ofWBV similar to Otsuki et al. (2008) of approximately 3%; 
ii) individuals with incomplete injuries will show a greater reduction in PWV following 
WBV compared to individuals with complete injuries as they have the availability of 
increased muscle activation; and iii) individuals with injuries below T5 will show a 
greater reduction in PWV following WBV compared to those with injuries above T5 due 
to a lesser degree of autonomic dysfunction. As found within the able-bodied population, 
we believe that PWV will have high intra- and inter-observer reliability for individuals 
with SCI. 
7 
Chapter 2 - Review of the Literature 
2.0 Epidemiology 
2.0.1 Demographics 
Sustaining a spinal cord injury (SCI) is a devastating and life-altering event. In the 
United States, there are 450,000 people living with a SCI or 1-2% of the population with 
a similar percentage found in Canada. In 1994, there were 10,000 new American cases 
and new cases were expected to rise to 13,400 per year by the year 2010 (Phillips et al., 
1998). In Canada, the annual incidence of SCI between 1997 and 2000 increased by 
greater than two-fold from approximately 21 individuals per million to 49 individuals per 
million (Pickett et al., 2006). Males sustain the vast majority of injuries, accounting for 
82% of all injuries. The majority of new injuries sustained occur between the ages of 16-
30 with a median age of 26 and the most common age of injury is 19 (Phillips et al., 
1998). Males and younger adults are believed to sustain the vast majority of injuries due 
to their greater propensity for high-risk behaviour. In Canada, motor vehicle accidents 
account for the highest number of SCI at 35%, followed by falls at 31 %, sport and 
recreation accidents at 13%, industrial accidents at 10%, and violence at 5% (DeVivo et 
al., 1999; Pickett et al., 2006). The cost of living with a SCI is very high. In the United 
States, the average first year expenses for individuals living with paraplegia amount to 
$152,000 and fIrst year expenses for individuals living with tetraplegia amount to 
$417,000. The average lifetime cost for individuals living with paraplegia with an onset 
of injury at age 25 has been estimated at $428,000 and the average lifetime cost for 
individuals living with tetraplegia with an onset of injury at age 25 has been estimated at 
$1.35 million (Gondim et al., 2004). 
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2.0.2 Classification a/Spinal Cord Injuries 
A SCI is classified with regard to both the level and severity of injury. If the 
neurological level of injury is C8 or above, then the individual is considered to be living 
with tetraplegia as the impainnent or loss of motor and/or sensory function occurs in the 
upper and lower limbs, trunk and pelvic organs. An individual with a neurological level 
of injury of Tl or lower is considered to be living with paraplegia as the motor and 
sensory function is nonnal in the upper limbs. 
Regarding injury severity, a SCI may be classified as complete or incomplete. A 
complete injury is defmed as an injury with complete loss of all motor and sensory 
functions at the S4-S5 level. An incomplete injury results in some degree of preservation 
of motor and/or sensory function at the S4-S5 level and therefore individuals living with 
incomplete injuries have spared motor or sensory function below the level of the lesion. It 
is important to note that individuals living with a complete SCI may still have some 
sensory or motor function below the level of the lesion despite lacking motor or sensory 
function at S4-S5. This 'zone of partial preservation' typically extends a few segments 
below the lesion level, after which there is no sensory or motor function. Of all 
individuals living with SCI, approximately 18% are living with complete tetraplegia, 
31 % are living with incomplete tetraplegia, 28% are living with complete paraplegia and 
23 % are living with incomplete paraplegia (Phillips et al., 1998). 
A more precise classification of injury severity is offered by the American Spinal 
Injury Association (ASIA). In this classification, injuries are divided into 5 subdivisions, 
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A-E, gradually decreasing in severity. Refer to Appendix B for further detail regarding 
these classifications. 
2.1 Cardiovascular Disease (CVD) and Dysfunction after Spinal Cord Injury 
2.1.1 Cardiovascular Disease and Spinal Cord Injury 
Perhaps the most striking effect of a SCI is the resulting immobility. However, a 
SCI also causes many life-threatening secondary consequences. Mortality is highest in 
the fITst year of injury, particularly for those with severe injuries. Factors that are 
considered for life expectancy include age, severity and level of injury as well as 
ventilator dependency (DeVivo et al., 1999). Respiratory and heart related complications 
account for over half of all deaths associated with SCI (DeVivo et al., 1999). However, 
with advancements in medicine and rehabilitation techniques, the life expectancy 
following an injury is increasing. As a result, individuals with SCI are becoming more 
prone to the typical age-related health risks and cardiovascular disease (CVD) is 
becoming a leading cause of mortality among the SCI population and the morbidity 
associated with CVD is more prominent at a younger age (Krassioukov et al., 2003). 
With an increasing long-term survival within the SCI population, CVD will continue to 
increase and account for greater morbidity and mortality (Groah et aI., 2001). 
2.1.2 Cardiovascular Dysfunction after SCI 
Following a SCI of the upper thoracic or cervical levels, the sympathetic nervous 
system (SNS) is disrupted and this results in subsequent autonomic dysfunction. 
Cardiovascular control is abnormal and unstable after a SCI, and is often characterized by 
long-term low levels of sympathetic activity interspersed with episodes of reflex 
sympathetic hyperactivity (Krassioukov & Weaver, 1995). Furthermore, there is an 
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inability of supraspinal vasomotor centres to effectively respond to cardiovascular 
reflexes and altered vascular tone (Phillips et al., 1998). 
The heart is innervated by SNS fibres that originate at the T 1-T 4 level. The 
postganglionic SNS fibres release norepinephrine which then acts on the sinoatrial (SA) 
and atrioventricular (A V) nodes, the walls of the ventricles as well as blood vessel walls 
to increase heart rate and the force of ventricular contraction as well as vasoconstriction 
of blood vessels. The PNS, via the vagus nerve, slows the heart rate and force of 
contraction. Therefore, cervical injuries as well as high-level thoracic injuries result in a 
great deal of autonomic dysregulation as the signals being sent by the SNS are interrupted 
causing a loss of sympathetic tone resulting in hypotension and bradycardia (Teasell et 
aI., 2000) while at the same time, the signals sent by the PNS are uninhibited via the 
influence of the vagus nerve (Krassioukov et al., 2007). In addition to the reduced levels 
of norepinephrine, there is a reduced sympathetic tone due to the reduced plasma 
epinephrine. This reduction in plasma epinephrine is· due to an interruption of the 
sympathetic nerves in the spinal cord that send the efferent signals from the · CNS to the 
adrenal medulla (Krassioukov et al., 2007). 
Importantly, the response of the cardiovascular system to exercise is affected by 
SCI. The SNS responds to exercise by causing a vasoconstriction at inactive muscles and 
the abdominal organs via the splanchnic nerves. Heart rate and contractility are also 
increased. These actions result in a greater venous return and end-diastolic volume and 
ultimately an increase in cardiac output. After a high level SCI, this sympathetic response 
is impaired, resulting in a reduced maximal cardiac output and consequent exercise 
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intolerance (Teas ell et al., 2000). Thus, rehabilitation strategies designed to reduce 
cardiovascular complications that do not employ traditional exercise are warranted. 
2.1.2.1 Autonomic Dysreflexia 
When prescribing exercise in this population, two important autonomic risks must 
be considered. The first is autonomic dysreflexia which is a potentially life-threatening 
phenomenon that affects 48-90% of individuals with SCI and is more common in those 
with an injury T6 and above (Bravo et al., 2004; Myers et al., 2007), although, it has 
been reported in individuals with injuries as low as T8-TI0 (Teasell et aI., 2000). 
Autonomic dysreflexia is a paroxysmal reflex of sympathetic activity in response 
to noxious or non-noxious stimuli below the lesion (Colachis & Clinchot, 1997). It is 
characterized by sympathetic hyperactivity below the level of injury causing moderate to 
severe vasoconstriction and hypertension with accompanying increases in stroke volume 
and cardiac output (Myers et al., 2007). Stimuli triggering the response may range in 
severity from an otherwise non-threatening pressure below the injury or a distended 
bladder, to a broken bone in the lower limb. 
Potential cardiovascular complications resulting from a bout of autonomic 
dysreflexia include left ventricular failure resulting in pulmonary edema, premature atrial 
and ventricular contractions, atrial fibrillation, tachycardia, myocardial ischemia and 
arrhythmias (Bravo et al., 2004; Colachis & Clinchot, 1997). Autonomic dysreflexia puts 
the population at a significant risk for acute coronary syndrome and cerebrovascular 
accidents and is the fourth leading cause of death from secondary impairments 
(Krassioukov et al., 2003). The cerebrovascular accidents include subarachnoid and 
intracranial hemorrhages and ischemic strokes. 
12 
Autonomic dysreflexia is caused by excessive peripheral responses to the release 
of catecholamines below the level of the lesion (Teas ell et a/., 2000). In addition, a SCI 
leaves the sympathetic activity below the lesion functionally separated from the 
inhibitory effects of supraspinal regulatory centres. As a result there is a loss of 
sympathetic integration and sympathetic activity becomes reflexive and highly excitable 
(Bravo et al., 2004). Vasomotor reflexes above the level of injury attempt to lower blood 
pressure by increasing parasympathetic stimulation to the heart via the vagus nerve which 
results in light headedness as well as vasodilatation and skin flushing above the lesion 
(Myers et al., 2007). 
2.1.2.2 Orthostatic Hypotension 
The second autonomic risk associated with exercise in this population is 
orthostatic hypotension. Orthostatic hypotension is defined as a decrease in systolic blood 
pressure of 20mmHg or more and a decrease of 10mmHg in diastolic blood pressure, 
upon the movement from a more supine position to a more upright position (Claydon et 
al., 2006). The decrease in blood pressure is associated with an increase in pulse rate as 
the individual assumes the upright position. The presence of orthostatic hypotension is 
greater among individuals with higher level and complete SCI (especially above T6) due 
to the inability to constrict the splanchnic blood vessels (Claydon et al., 2006). 
Orthostatic hypotension may also result from the reduced pumping action of the skeletal 
muscles, which reduces the venous return to the heart. This in turn reduces stroke 
volume, cardiac output and blood pressure (Gondim et al., 2004). 
Orthostatic hypotension affects the individual's ability to participate in activities 
that provoke drops in blood pressure and as such, causes a reduction in quality of life. It 
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also affects activities of daily living and participation in rehabilitation programs, and 
causes a deficit in cognitive performance and an increase in fatigue (Gondim et aI., 
2004). 
Autonomic dysreflexia and orthostatic hypotension are autonomic dysfunctions 
that decrease the quality of life for individuals living with SCI. It is important to take 
precautions during activity and exercise to monitor and prevent the development of these 
dysfunctions from occurring. 
2.3 Risk Factors Contributing to the Development of CVD 
The high prevalence of CVD in the SCI population is caused by risk factors 
resulting from altered autonomic function as well as the sedentary lifestyle that arises due 
to the injury. Many of the risks associated with CVD in individuals with a SCI are similar 
to those of an untrained, able-bodied individual (Groah et al., 2001). This illustrates the 
direct consequence of the sedentary lifestyle that is typically adopted post-injury on 
cardiovascular health. Altered autonomic function as previously mentioned, diminished 
physical exercise, altered lipid profiles and a reduced glucose tolerance are some of the 
risk factors ofCVD in SCI (Groah et al., 2001). As well, arterial stiffness has been 
described as an independent risk factor for CVD (Arnett et al., 1994; Glasser et al., 
1997). Although this thesis is primarily concerned with arterial compliance after SCI, a 
brief discussion of all of the above risk factors is warranted, as they are interrelated in 
their detrimental effects on cardiovascular health. 
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2.3.1 Insulin Insensitivity 
As a consequence of inactivity, the body fat percentage in the SCI population is 8-
18% higher than age-matched, able-bodied individuals (Buchholz & Bugaresti, 2005). 
Intramuscular fat impedes glucose metabolism and is highly correlated with insulin 
insensitivity (Elder et al., 2004). Elder and colleagues (2004) reported that SCI subjects 
with higher intramuscular fat also had higher glucose and insulin values after glucose 
ingestion during the oral glucose tolerance test than able-bodied individuals with a 
similar diagnosis of diabetes mellitus. However, these subjects with SCI also had a 
reduced muscle cross-sectional area, which in tum, influences glucose and insulin values 
following an oral glucose tolerance test. Therefore, high intramuscular fat in conjunction 
with a decrease in muscle cross sectional area worsens insulin insensitivity. Diabetes 
mellitus has been found to be high among the SCI population, with a prevalence of nearly 
23% of the total population (Myers et ai., 2007). An individual with a SCI has a two-fold 
increase in the risk of cardiovascular mortality after being diagnosed with diabetes 
mellitus (Myers et ai., 2007). 
2.3.2 Altered Lipid Profile 
Dyslipaedemia, a high antherogenic ratio of total cholesterol or low-density 
lipoprotein (LDL) to high-density lipoprotein (HDL), is another metabolic alteration that 
occurs with serious adverse effects. Individuals living with tetraplegia have a greater 
degree of dyslipaedemia, in tum increasing their risk for CVD (Myers et al., 2007). The 
dyslipaedemia occurs as a result of high post-load insulin and low levels of physical 
activity. Serum levels ofLDL have been shown to be very similar when comparing able-
bodied and SCI subjects (Myers et al., 2007). The increased dyslipaedemia risk in the 
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SCI population lies in their reduced amount of serum HDL which is largely due to 
physical inactivity (Myers et al., 2007). 
HDL and LDL have a potent influence on the atherosclerotic process (Bauman et 
al., 1999). LDL can penetrate the endothelial wall of a blood vessel and contribute to the 
creation of lipid foam cells, which form the core of a plaque deposit. When LDL is 
oxidized, it also triggers an inflammatory response within the endothelium accelerating 
the process of atherosclerosis. HDL is responsible for reversing the oxidation ofLDL and 
as such, a high serum LDL coupled with a low serum HDL increases the risk of CVD 
(Bauman et al., 1999). An increase in the cardiopulmonary fitness of an individual with 
SCI has been shown to positively influence the serum HDL cholesterol (Bauman et al., 
1999). Individuals living with tetraplegia who were regularly active in aerobic exercise as 
shown by a greater V02 peak (mllminlkg) had a HDL level of 1. 13mmollL in comparison 
to the HDL level of 0.95mmollL in sedentary individuals living with tetraplegia 
(Dallmeijer et al., 1997). 
2.3.3 Deep Vein Thrombosis 
Deep vein thrombosis (DVT) is a major risk to the SCI population. A pulmonary 
embolus occurs when a thrombus detaches from a blood vessel and travels to the 
pulmonary arteries and blocks the blood flow to the lung; an event that is often fatal 
(Bravo et al., 2004). While a DVT occurs in up to a third of individuals living with long-
term SCI, the highest risk occurs acutely after the SCI. Acutely, 67-100% of these 
patients experience a DVT and consequently a pulmonary embolism is the third most 
common cause of death after SCI (Green et al., 2003). 
16 
Individuals with SCI are more predisposed to thromboembolism due to the 
combination of peripheral venous stasis, intimal injury and platelet hypercoagulability 
(Kahn et al., 2001). Venous stasis results from a lack of neurologic control in the vessels 
as well as in the voluntary muscles, as there is limited to absent muscle pump activity 
(Bravo et al., 2004). A DVT occurs most often in the lower limbs. This can be attributed 
to vascular adaptations to inactivity and muscle atrophy, which considerably impair 
venous return from the lower extremities (Bravo et aI., 2004). Individuals with SCI have 
up to three times greater levels of platelet derived growth factor (PDGF), a known 
facilitator of platelet aggregation, than the able-bodied population and consequently have 
an increased risk for thrombus formation due to hypercoagulability (Kahn et al., 2001). 
2.3.4 Decreased Arterial Compliance 
Arterial compliance is the ability of a blood vessel wall to expand and contract 
passively to an increase in volume when pressure changes occur. It is defined as the 
change in volume divided by the change in pressure. A decrease in arterial compliance is 
associated with many cardiovascular risk factors including age, gender, lipoprotein 
abnormalities and diabetes mellitus (Arnett et aI., 1994). Arterial compliance decreases 
with age and typically, women exhibit a lower arterial compliance than men beginning at 
a younger age (Noon et al., 2008; Vermeersch et al., 2008). Reduced arterial compliance 
is often associated with several disease states within the cardiovascular system such as 
isolated systolic hypertension, left ventricular hypertrophy, congestive heart failure and 
orthostatic hypotension (Tanaka et al., 2000). A decreased level of arterial compliance is 
associated with coronary arterial events such as myocardial infarction (N akae et al., 
2008), atherosclerosis (Arnett et al., 1994) and an increase in systolic blood pressure 
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(Arnett et al., 1994; Hermeling et al., 2007). 
The arterial system is designed as a network of vessels designed to convert the 
intermittent flow of blood from the heart to a continuous flow across the arterial tree, thus 
reducing the afterload imposed on the heart (Boreham et al., 2004). Larger arteries 
instantaneously accommodate the volume of blood ejected from the heart and store part 
of the stroke volume during the systolic ejection, and via the elastic recoil of the muscular 
arterial vessels, drain the volume during diastole (Safar, 2001). Arterial compliance is 
reflected by the blood vessels' ability to expand and recoil with cardiac pulsation and 
relaxation (Tanaka et al., 2000). Although blood flow is continuous, there is a pulse in 
blood vessels that is caused by a pressure wave that travels along the arteries. This wave 
is in response to the blood being pushed into the arteries during systole causing the 
arterial walls to expand. The compliance is a measure of the relationship between 
pressure and volume changes. In vessels with low compliance, a small increase in blood 
volume causes a large increase in blood pressure. Therefore as a vessel becomes less 
compliant, there is a greater rise in the pulse pressure (Kingwell, 2002). Compliance of 
the proximal aorta is the principal determinant of central pulse pressure. Larger arteries 
with decreased compliance cause the pulse pressure to rise due to higher systolic and 
lower diastolic pressure (Kingwell, 2002). 
2.3.4.1 Effects o/Decreased Compliance on the Cardiovascular System 
Due to the decreased compliance caused by arterial stiffening, the arteries cannot 
adequately accommodate the volume ejected by the left ventricle (Hermeling et al., 
2007). The greater flow velocity attributed to the diminished arterial compliance causes 
wave reflections to return towards the aortic valve earlier in the cardiac cycle ultimately 
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arriving during the ejection phase causing the rise in systolic pressure (Abhayaratna et 
at., 2008; Hermeling et al., 2007). Thus, the same stroke volume will result in a higher 
pulse and systolic blood pressure. The increased afterload on the ventricle results in an 
increased myocardial oxygen demand and results in decreased oxygen supply to the heart 
(Boutouyrie et at., 2002). The left ventricular hypertrophy and the elevation of systolic 
blood pressure ultimately lead to long-term raised left ventricularafterload and 
myocardial work. This results in a further reduction in coronary perfusion and thus leads 
to subendocardial ischaemia (Boutouyrie et al., 2002). 
2.3.4.2 Factors Determining Arterial Compliance 
Arterial compliance is determined by structural and functional components and 
the intrinsic elastic properties of the artery (Arnett et al., 1994). Structurally, the three 
layers and the lumen of the blood vessels affect arterial compliance. The innermost layer 
is the thinnest layer and is known as the tunica intima. It is composed of a single layer of 
simple squamous endothelial cells surrounded by a thin layer of subendothelial 
connective tissue interlaced with a number of circularly arranged elastic bands called 
internal elastic lamina. The outermost layer is known as the tunica adventitia and it is 
made entirely of connective tissue. The tunica media is the middle and thickest layer and 
has the greatest influence on arterial compliance. It is composed of circularly arranged 
elastic fibers, connective tissue and polysaccharide substances, and is separated from the 
inner layer by a thick elastic band known as the external elastic lamina. The innermost 
tissue of this layer is composed of elastic and smooth muscle that allows for the control 
vessel diameter. Elastin and collagen fibres compose the elastic tissue. When the artery is 
healthy, the proportion of elastin and collagen is held stable by a slow and dynamic 
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process of production and degradation (Zieman et al., 2005). When this process is 
disrupted, there is vascular tissue dysregulation caused by stimulation of inflammatory 
molecules. This causes an overproduction of abnormal collagen and diminished 
quantities of normal elastin contributing to vascular stiffness and a decrease in 
compliance (Arnett et al., 1994; Zieman et al., 2005). As well, elevated smooth muscle 
tone or smooth muscle cell growth increases arterial stiffness (Arnett et al., 1994). 
Functional determinants of compliance are related to neurohumeral influences 
such as the renin-angiotensin system (RAS), (Glasser et al., 1997). The RAS 
predominantly acts as a vasoconstrictor on arterioles. As well, this system has the ability 
to induce and elevate arterial stiffness by altering collagen and elastin thereby causing 
endothelial dysfunction by increased production of angiotensin II (Mahmud, 2004). 
Angiotensin II increases aortic pulse pressure without any noticeable changes to 
peripheral pulse pressure. Angiotensin II activity leads to collagen degradation, smooth 
muscle proliferation and the development of fibrosis which account for many of the 
underlying pathophysiological mechanisms that decrease arterial compliance (Mahmud, 
2004). In a review by Zieman (2005) it was reported that diminished central arterial 
compliance and insulin resistance are positively correlated. Long-term hyperglycemia 
and hyperinsulineamia increase the local activity of the rennin-angiotensin-aldosterone 
system. This leads to the increased expression of the angiotensin type-1 receptor in 
vascular tissue. This increase in the angiotensin type-1 receptor is thought to initiate an 
inflammatory response promoting the development of wall hypertrophy and fibrosis 
leading to decreased arterial compliance. 
Furthermore, reduced arterial compliance further increases the risk for 
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atherosclerosis. When the walls of the vessel are thickened, for any given blood volume 
flowing through the vessel, the smooth muscle cells are mechanically stretched more 
forcefully due to a greater pressure. This stretching of the smooth muscle cells results in 
an increase in collagen synthesis in the vessel wall further decreasing compliance (Arnett 
et ai., 1994) as well as causing arterial wall hyperreactivity (Laurent et aI., 2001). In 
addition, the forced stretching of the arterial wall augments · the endothelial surface area. 
This increase in surface area causes an increase in intimal permeability to cohesive 
molecules such as albumin, lipoproteins and leukocytes ultimately leading to 
atherosclerotic plaque formations in the artery (Arnett et al., 1994). 
2.3.4.3 Arterial Compliance and Altered Lipid Profile 
Noon and colleagues (2008) demonstrated that an increase in total cholesterol and 
LDL levels were associated with increases in both central and peripheral blood pressures. 
Elevated LDL levels were also associated with increased peripheral and central pulse 
pressures reflecting an increase in arterial stiffuess. This can be attributed to endothelial 
dysfunction caused by the high levels of LDL 
2.3.4.4 Arterial Compliance and Diabetes Mellitus 
As previously mentioned, the SCI population has a high prevalence of diabetes 
mellitus and type-2 diabetes has been discussed as a risk factor for CVD. Diabetes 
mellitus also has an influence on arterial compliance by causing endothelial dysfunction. 
It has been shown that elevated levels of plasma glucose cause connective tissue damage 
within the vessel (Glasser et aI., 1997). By affecting the connective tissue in an artery, the 
compliance is decreased as the vessel is no longer able to stretch the required amount in 
order to accommodate the blood being ejected through the artery. 
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2.3.4.5 Arterial Compliance and DVT 
Although the direct relationship of arterial compliance and DVT has not been 
examined within the literature, a reasonable link can be made. With arterial stiffness, 
there is damage that is occurring to the vessel and further damage is likely during 
pulsatile changes in blood pressure. As the vessel is further damaged, the immune system 
attempts to repair it by greater platelet formation over the damaged area. With greater 
platelet formation and greater platelet aggregation in individuals with SCI as previously 
mentioned, there is a potentially increased risk of a thrombus being formed and 
dislodging from the vessel wall. 
2.3.4.6 Arterial Compliance and Individuals living with SCI 
Within the able-bodied population, diminished degrees of arterial compliance are 
associated with increased age, male gender, lipoprotein abnormalities, diabetes mellitus, 
obesity, lower physical activity levels and poor cardiovascular fitness (Miyatani et al., 
2009). Individuals living with SCI have lower physical activity levels and a resulting 
lower cardiovascular fitness (Phillips et a/., 1998). 
Finally, people with SCI are at increased risk of pressure sore development due to 
poor tissue perfusion (Kanj et al., 1998). Reduced arterial compliance in the peripheral 
vessels may reduce the blood flow to tissues supplied by the stiffer vessels. 
Thus, reduced arterial compliance has important effects on the cardiovascular 
system and reducing the arterial stiffness may reverse the associated cardiovascular 
disease in the SCI population. 
2.4 Assessment of Arterial Compliance 
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2.4.1 Augmentation Index and Carotid Intima-Media Thickness 
Augmentation index (AI) and carotid intima-media thickness have been used to 
assess arterial compliance. AI can be considered a measurement of the functional 
component of arterial compliance. As the wave of the pulse pressure travels along the 
arterial tree, it encounters resistance in the arterioles of the periphery and the wave is 
subsequently reflected back to the heart. In healthy elastic arteries, the wave is reflected 
back during diastole. However, with a decrease in arterial compliance, the pulse pressure 
wave travels much more quickly along the arterial tree, thus arriving earlier in the cardiac 
cycle; specifically during systole. These early reflections in the aorta augment the systolic 
pressure so that the absolute systolic pressure is increased (Mahmud, 2004). Therefore in 
stiffer or less compliant vessels, there is a first systolic peak of pressure at ejection, plus a 
second peak resulting from the early reflective wave returning to the aorta before the end 
of systole (Mahmud, 2004). As such, the difference of the first peak and the second peak, 
due to the reflected wave, is the AI. Therefore, a higher AI results from reduced arterial 
compliance. 
Carotid intima-medial thickness (CIMT) is a marker of structural vessel wall 
properties (Djaberi et al., 2008). An increase in CIMT results in stiffening of a vessel and 
thus is a marker of reduced arterial compliance. 
2.4.2 Pulse Wave Velocity 
Pulse wave velocity (PWV) assessment is a topical detection method developed 
as a non-invasive diagnostic tool for the measurement of arterial compliance. As the 
ventricle ejects the stroke volume during systole the elastic properties of the arterial 
vessels expand with the increased pressure. During diastole, the ventricle relaxes and the 
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elastic walls of the vessels then recoil and move the blood volume forward creating a 
pulse. The change in the pressure between systole and diastole is the pulse pressure. The 
pulse travels along the arterial vessels as a wave of change of pressure. The speed of the 
wave is directly affected by the compliance of the vessels; a slower velocity being 
associated with greater compliance. PWV is an indirect evaluation of arterial compliance 
that is negatively correlated with arterial compliance; thus, the higher the PWV, the lower 
the arterial compliance and the stiffer the vessel. PWV has been shown to predict 
cardiovascular outcomes, independent of traditional risk factors (Abhayaratna et al., 
2008). 
The methods of assessing arterial compliance such as AI, CIMT and PWV are all 
accepted techniques. However, there is no direct comparison among the measurements. 
For example, there is no record of what level of AI will correlate with a particular PWV. 
Although this is the case, assumptions may be postulated regarding the various methods. 
As a higher AI is indicative of a pulse pressure wave reflecting back to the heart at a 
higher speed, it may be assumed that it is also correlated with a higher PWV. Similarly, 
increased CIMT indicates increased vessel wall stiffness and therefore it may be 
associated with a faster pulse pressure wave velocity. Further research is required to 
establish meaningful links between these measurement techniques. 
Taquet and colleagues (1993) found that PWV was directly associated with 
systolic and diastolic blood pressure. The association between high systolic blood 
pressure and a high PWV value may be related to the long-term increased blood pressure 
causing more forceful passive stretching of the collagen fibres of the blood vessel walls. 
This increased mechanical stretch will cause an increased production of collagen fibres 
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which results in further arterial stiffness (Taquet et al., 1993). In addition, PWV was 
directly associated with biological variables such as heart rate, age, total cholesterol, 
LDL, triglycerides, apolipoprotein B, fasting glucose and BMI but not with HDL, 
apolipoprotein Al and fibrinogen (Taquet et al., 1993). 
2.4.3 Methods o/Measuring PWV 
Pulse wave velocity testing is performed by measuring the speed of the blood 
pressure wave as it travels between two sets of anatomical points within the arterial 
system (Miyatani et al., 2009). A transcutaneous Doppler probe is placed at each site and 
the pulse waveforms are recorded. The time delay between the beginning of the systolic 
upstroke at each site is measured. The PWV is calculated as the distance travelled divided 
by the measured wave latency between the two arterial recording sites and it is usually 
expressed in cm/s (Miyatani et al., 2009). Aortic PWV values greater than 1300cmls have 
been directly linked with cardiovascular mortality, fatal and non-fatal coronary events, 
and fatal strokes in patients with either low or high levels of traditional CAD risk factors 
(Miyatani et al., 2009). 
2.4.4 Methods 0/ Assessing PWV 
There are two sites of measurement used for PWV. The first is 'global' or 
'central' PWV which measures long arterial trajectories and is most commonly measured 
between the carotid and femoral artery (Hermeling et al., 2007). This global measure best 
describes the PWV along the aorta. The aorta is a major vessel of interest for many 
reasons. First, the aorta evolves from a large, elastic artery in the thoracic area to a more 
muscular vessel within the abdomen and iliac bifurcation and therefore cannot be 
categorized as either elastic or muscular but likely reflects a mix of properties related to 
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both (Vermeersch et at., 2008). In addition, the thoracic and abdominal aortas are the 
largest contributors to arterial buffering function and aortic PWV is an independent 
predictor of outcome in many populations (Laurent et at., 2006). One disadvantage of 
measuring central PWV is that the carotid and femoral pulse waves travel in opposite 
directions. This causes a chance of error in distance measurement as they are done 
topically. As such, the distance from the carotid artery to the femoral artery may be 
underestimated. Therefore, the use of the topical distance between carotid and femoral 
artery may cause an overestimation of the PWV (Hermeling et at., 2007), however, so 
long as a consistent measure is used, this technique may be ideal for detecting changes in 
central PWV before and after an intervention. 
The second method is known as 'local' or 'peripheral' PWV. In this method, the 
blood pressure wave is measured along a small arterial trajectory, such as the brachial 
artery to the radial artery or the femoral artery to the posterior tibial artery (Hermeling et 
at., 2007). Although global PWV, or PWV measured along the aortic and aortoiliac 
pathways, is more clinically relevant as the aorta and its first branches are responsible for 
most of the pathophysiological effects of arterial compliance (Boutouyrie et at., 2002), it 
is important to measure peripheral PWV as well. The measurement of peripheral PWV 
determines whether localized exercise using the upper and lower limbs affects arterial 
compliance in these limbs. For example, whole-body vibration may have the effect of 
increasing arterial compliance in the vessels of the lower limbs. This is important for 
individuals living with a SCI, as it may potentially help to decrease the risk of a DVT 
formation. 
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2.4.5 PWV and Individuals with SCI 
PWV has been shown to be a useful and effective non-invasive measure to 
evaluate arterial compliance and severity of CVD among able-bodied people (Boutouyrie 
et al., 2002; Taquet et al., 1993). Few studies known to date have investigated the use of 
PWV with individuals with SCI. Miyatani and colleagues (2009) compared a cohort of 12 
individuals with SCI to age, gender, height and weight matched able-bodied controls. 
Participants from both the SCI and control groups were excluded if they had a history of 
CVD or current metabolic syndrome. This study found that mean aortic PWV was 
significantly greater in the SCI group than the control group (1274 ± 369cm/s to 948 ± 
110cm/s, p<0.05). However, no significant differences were seen when arm and leg PWV 
values were compared. This was thought to be due to the fact that aortic PWV is sensitive 
to the level of daily activity and aging whereas arm or leg PWV is not. Also, because the 
central arteries have the function of dampening the central fluctuations in flow they may 
undergo more adaptations leading to a loss of elasticity than the peripheral arteries. This 
is in contrast to the study by J ae and colleagues (2008) that noted a decrease in 
compliance in the femoral artery in people with SCI as measured by augmentation index. 
The disparity in these findings warrants further study of the effects of SCIon arterial 
compliance. Mechanisms that may potentially account for the higher aortic PWV among 
individuals with SCI are the structural changes in the vessel as a result of long-term 
sympathetic dysfunction, increased collagen content in the vascular wall and functional 
changes in the endothelium caused by a decrease in regional blood flow (Miyatani et al., 
2009). The experiment performed by Miyatani and colleagues (2009) compared 
individuals with SCI and able-bodied individuals who did not have a history of CVD or 
metabolic syndrome. These results, which demonstrate a higher PWV among the SCI 
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population, may indicate reduced arterial compliance predisposing them to increased risk 
of cardiovascular events. 
2.4.6 Inter- and Intra-Observer Reliability ofPWV 
Pulse wave velocity has been shown to be a valid and reliable estimate of arterial 
stiffness in able-bodied individuals. A study conducted by Lehmann et al. (1992) 
determined the coefficient of variation (CV) of intra- and inter- observer repeatability of 
aortic PWV in healthy individuals. The results showed a CV of 8.5% intra-observer and 
9.4% inter-observer repeatability (Lehmann et al., 1992). In addition, studies by Lee et 
al. (2009) and Naidu et al. (2005) used correlations to examine intra- and inter-observer 
reliability for various PWV measurements along the arterial tree. In 17 healthy subjects, 
intra-observer test-retest values for aortic, arm and leg PWV were highly repeatable 
within each vessel with r-values between 0.94 and 0.99 (p<0.01). Inter-observer test-
retest values for aortic, arm and leg PWV showed a more variable degree of repeatability 
among vessels, with r-values of 0.93, 0.50 and 0.58, respectively (p<0.05) (Lee, 2009). 
Similarly, in the study by N aidu et al. (2005), heart-brachial, heart-ankle, brachial-ankle, 
and carotid-femoral PWV were tested in 44 healthy individuals in addition to individuals 
with CVD. Intra- and inter-observer correlations were found to be significant (p<0.0001) 
with r values greater than 0.71 (Naidu et al., 2005). However, one study found a 
significant intra-observer difference for aortic PWV despite no significant inter-observer 
difference. There was also no difference found for intra- or inter-observer brachial PWV 
(Frimodt-Moller et al., 2008). Therefore, despite the demonstrated repeatability ofPWV, 
it may still be necessary to conduct inter- and intra-observer repeatability calculations to 
ensure proper interpretation of results. As they have never been evaluated after SCI, 
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future studies should determine the inter- and intra-observer reliability for PWV in this 
population. 
2.5 Benefits of Exercise for Individuals with a SCI 
2.5.1 Arterial Compliance and Exercise 
The effect of exercise on arterial compliance has been studied in the able-bodied 
population. The Baltimore Longitudinal Study on Aging showed that older endurance-
exercise trained males demonstrated a lower aortic PWV and carotid augmentation index 
than their sedentary male peers (Vaitkevicius et al., 1993). In a study by Boreham et al. 
(2004), males and females participated in an evaluation of their V02max as well as a PWV 
measurement of the central and peripheral vessels. Participants also answered a 
questionnaire about their exercise and sport participation. The central and peripheral 
PWV's were significantly and inversely related to V02max and participation in sport 
exercise was significantly and inversely related to the peripheral PWV but not the central 
PWV. It was thought that sport had a greater effect on the periphery with increased blood 
flow through the limbs causing the release of nitric oxide from the endothelium as well as 
some structural remodeling of the vessels (Boreham et al., 2004). Age- related decreases 
in arterial compliance have been shown to be attenuated by aerobic exercise training 
(Tanaka et al., 2000). With the increased arterial compliance due to aerobic training, the 
time to exhaustion increased by 20% and the heart rate and ratings of perceived exertion 
at the same absolute submaximallevel of exercise decreased (Tanaka et al., 2000). 
Heffernan et al. (2007) measured aortic PWV 20 minutes after an acute bout of 
endurance (30 minutes, 65% V02max) or strength training (3 sets of 10 repetitions at 
100% of 10-repetition maximum) exercise in recreationally active men. The results 
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showed that arterial compliance was increased following the acute endurance exercise, 
while after the acute resistance exercise, arterial compliance was decreased. The acute 
changes due to aerobic exercise were thought to be due to intrinsic changes in arterial 
wall properties and not changes in vascular pressure as the changes were independent of 
mean arterial pressure. Otsuki et al. (2007) measured arterial compliance in endurance 
and strength trained athletes who had been training for over 2 years (long-term effects), 5 
times per week at 3 hours per week. To account for the differences in arterial compliance 
after strength and endurance training, these authors also measured plasma endothelium-l 
levels and plasma nitric oxide. The results showed that plasma nitric oxide did not differ 
but plasma endothelium-l levels were greater in magnitude by 20% after strength training 
and thus may playa role in the different adaptations of arterial compliance following 
endurance and strength training protocols. Another study performed by Maeda, et al., 
(2008) evaluated arterial compliance in older women after an acute bout of endurance 
exercise before and after an endurance training protocol. Interestingly, the acute exercise 
did not cause an increase in arterial compliance before training but did cause a significant 
increase following the exercise training protocol. 
In contrast to aerobic training, resistance training increases proximal aortic 
stiffness and is associated with higher incidence of left ventricular hypertrophy compared 
to sedentary controls (Zieman et al., 2005). Lastly, it has been found that stiffer vessels at 
rest experience higher pulse pressure at maximal exercise. This pressure, in turn, may 
limit cardiac output by increasing the energetic cost for the heart to maintain adequate 
blood flow (Kingwell, 2002). Therefore, it follows that when a population is susceptible 
to arterial events due to a decrease in arterial compliance, there may be value in 
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implementing an aerobic exercise program that may increase arterial compliance and 
reduce the associated cardiovascular risk. Therefore, these studies establish a link 
between aerobic exercise and arterial compliance, and the well-documented association 
of aerobic exercise benefits to cardiopulmonary fitness. 
2.5.2 Challenges o/Exercise/or Individuals with SCI 
Exercise is a main component and important aspect of what is considered to be a 
healthy lifestyle. The many benefits of exercise for the able-bodied population have been 
very clearly described within the literature (Hopp, 1993; Mayo & Kravitz, 1999; Morris 
& Froelicher, 1993). For individuals with SCI, the benefits from exercise are at least as 
important. This is due to the secondary health complications and associated morbidity 
and mortality attributed to the sedentary lifestyle that commonly follows the injury. The 
SCI population falls within the low end of the physical activity spectrum (Elder et aI., 
2004). High-level thoracic and cervical injuries cause the greatest loss in muscle mass 
affecting prime movers and stabilizers of the trunk making exercise more difficult to 
complete. The cardiovascular power of an individual living with a SCI is substantially 
lower than the able-bodied population. The average V02max for individuals living with 
tetraplegia was found to be only 12mL/kg/min (de Groot et al., 2006). Unfortunately, 
exercise within this population is more difficult than for the able-bodied population, and 
exercise options are severely limited. As mentioned, autonomic disruption, due to the 
lesion in the spinal cord, causes physiological responses to exercise to differ in the SCI 
population in comparison to the able-bodied population (Nash, 2005). Following an 
injury above T6, substantial adrenergic dysfunction occurs, decreasing regulatory input 
and altering the cardiovascular efficiencies achieved by able-bodied exercisers (Nash, 
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2005). In the able-bodied population, the sympathetic nervous system vasoconstrictor 
responses serve to increase the venous return and improve the end diastolic ventricular 
volume while heart rate and myocardial contractility increase. With high level and 
complete SCI, there is reduced sympathetic efferent output with lack of vasoconstriction 
and a reduced contractility response, however, there is some increased heart rate response 
as a result of reduced vagal withdrawal (Teas ell etal., 2000). 
Not only is it more physically difficult for individuals with SCI to exercise, it has 
been shown that exercise adherence is also a problem in this population. In a study 
conducted by Anderson in 2004, 681 individuals living with a SCI were surveyed 
regarding the importance of exercise in their rehabilitation programs. Of these 
participants, 96.5% believed exercise was important and vital to their functional recovery, 
but only 57% had access to suitable exercise equipment and only 45% of this sub-group 
had access to a trained therapist (Anderson, 2004). To stress the importance of exercise 
adherence, Ditor et al., (2003) measured pain, stress and perceived quality of life 3 
months following a 9 month training protocol. During the 9 months of exercise training, 
pain and stress decreased by approximately 1 0% and perceived quality of life increased 
over 15%. In the 3-month follow up, exercise adherence decreased compared to during 
the 9-month program (42.7 versus 80.6%, respectively) and as a result pain and stress 
increased by 30% and 35% respectively. As well, there was a 10% decrease in perceived 
quality of life (Ditor et al., 2003). Therefore, although exercise is necessary in order to 
maintain exercise-related increases in psychological well-being, adherence to exercise 
has shown to be a notable obstacle after SCI. 
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Aerobic exercise studies have been shown to raise arterial compliance in the able-
bodied population (Tanaka et at., 2000; Thijssen et al., 2007). Likewise, aerobic exercise 
may also be beneficial for the SCI population and early studies have confirmed such a 
benefit. For example, Jae et al., (2008) compared individuals living with paraplegia who 
regularly participated in aerobic exercise to recreationally active, age-matched, able-
bodied controls. The results showed that regular exercise for individuals living with SCI 
eliminated any differences in mean carotid intima media thickness when compared to 
able-bodied controls. Therefore, aerobic exercise may help to preserve arterial function in 
individuals living with SCI (Jae et al., 2008). 
2.5.3 Modalities and Cardiovascular Benefits of Exercise 
Common modalities of exercise, which significantly affect cardiovascular 
outcomes for individuals with SCI, include arm ergometry, body-weight supported 
treadmill training (BWSTT) and functional electrical stimulation (FES). Arm ergometry 
is most commonly used for endurance training and improvements in aerobic capacity. 
Studies have shown that arm ergometry can improve physical conditioning by an average 
of 15-25% (Cowell et al., 1986; Davis et al., 1981; Franklin, 1985). However, this 
modality is limited to those with fully or highly functioning upper limbs, as individuals 
living with low level tetraplegia who performed this exercise had their gains in peak 
oxygen uptake fail to approach those of individuals with lower level injuries (Yim et al., 
1993). Therefore, the more disabled individuals within the SCI population may not 
benefit from this form of exercise. 
Ditor and colleagues (2005) used BWSTT for individuals with motor-complete 
injuries and investigated the effects on vessel cross-sectional area, blood flow, vessel 
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resistance and arterial compliance. Following four months ofBWSTT, there was no 
significant exercise induced change in femoral and carotid cross-sectional area, blood 
flow or resistance. However, femoral arterial compliance significantly increased by 
approximately 50%. As well, Phillips and colleagues (2004) found that BWSTT 
decreased the risk for type-2 diabetes by decreasing resting plasma glucose levels and 
increasing GLUT-4 content, glycogen, ATP and PCr, ultimately leading to an improved 
glycemic regulation. By reducing the risk of type-2 diabetes, the risk for subsequent 
changes in the arterial endothelium are reduced and may have an effect on reducing 
arterial stiffness. A drawback of BWSTT is that it is a very expensive and labour 
intensive form of exercise. The average individual living with a SCI will be unable to 
perform this type of exercise at their own home. Therefore, it is necessary to identify a 
form of exercise that is less expensive and can be performed with minimal assistance to 
allow for individuals living with SCI to exercise at home. 
Lastly, FES has shown promise as a cardiovascular stimulus. Enhanced levels of 
fitness have been shown following FES exercise (Mutton et aI., 1997) and it has been 
shown to reverse the adaptive left ventricular atrophy reported in individuals living with 
tetraplegia by significantly improving lower extremity circulation following training 
(Gerrits et aI., 2001). Thus, FES has a positive effect on reducing the risk ofCVD in 
individuals living with tetraplegia. However, there are risk factors to this form of exercise 
including pain in those with spared sensation, and lack of response in those with lower 
motor neuron injuries. 
2.6 Whole-Body Vibration (WBV) 
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2.6.1 What is WBV? 
Whole-body vibration (WBV) is a relatively new form of exercise that has been 
explored as a means to benefit the musculoskeletal system as well as the cardiovascular 
system, and it typically entails individuals performing dynamic or static exercises, such 
as a squat, while standing on a vibrating platform. During this form of exercise, the 
vibrations emanating from the platform cause the human body to oscillate, thus causing a 
reactive force within the body (Rittweger, 2010). The platform oscillates vertically or in a 
sinusoidal direction at a specific frequency and amplitude. The frequency (Hz) represents 
the rate at which the platform vibrates and the amplitude (mm) represents the vertical 
displacement of the platform. Typically, frequency ranges between 26 to 45Hz and the 
amplitude ranges between 1-6mm. The human body is not rigid and has muscles and 
tendons that can store and release mechanical energy. In WBV, compression occurs 
during the vibration upstroke, and the opposite expansion occurs during the downstroke 
(Rittweger, 2010). The compression forces are believed to cause an increase in shear 
force along the vessel walls which is thought to cause deformation of the vessel. 
Deformation of a vessel stimulates the endothelial cells to release nitric oxide (NO) and 
promote vasodilatation (Chen et al., 2002). Moreover, as the vibrations are transmitted 
through the body, they elicit a stretch reflex in the muscles. The vibrations cause the 
stretch of muscle fibres and the sensory organs within the muscles known as the muscle 
spindles. The muscle spindle sends a positive excitation signal to the alpha motor neuron 
of the muscle and causes a muscle contraction (Rittweger, 2010). This neuromuscular 
response is known as the 'tonic vibration reflex'. This reflex is thought to have the 
potential to increase the recruitment of motor units (Seidel, 1988). While an individual is 
performing a squat or other dynamic exercise, the positive stimulus of the vibration is 
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summated with the volitional positive excitation of muscle activation and results in the 
firing of more motor units with an augmented muscle force of contraction. This has the 
potential to produce an increase in strength development during an exercise program 
(Rittweger, 2010). 
The waves of vibration are transmitted from the feet throughout the muscles of 
the body. As the vibration travels more proximally from the feet, the strength of the 
vibration is reduced (Rees et al., 2008). In addition, the angle of knee and hip flexion are 
determining factors as to how high the vibration travels within the body. While standing 
fully erect, or nearly erect, with knees locked in extension, the vibration is transferred to 
the upper body, which may cause discomfort due to the shaking of the head and eyes 
(Rees et al., 2008). Therefore, with individuals being placed in a squatting position where 
the weight is posed on the forefoot, the resonance of the vibration is dissipated in the 
abdomen thus minimizing the discomfort individuals experience (Rittweger, 2010). 
2.6.2 Benefits of Long-term WBV Training 
Assessment of the long-term training effects of WBV have mainly focused on 
muscular strength (Mester et aI., 2006; Roelants et al., 2004) and have shown that 
vibrations induced increases of 5 to 35%. For example, a one year study ofWBV training 
was conducted on adults over the age of 60 (Bogaerts et al., 2009). This study had the 
participants dynamically exercising on the vibration platform. It was found that V02 peak 
increased by 18% following the vibration training and there was a 9.4% increase in 
muscular strength. In addition, heart rate increased to 62% of the heart rate reserve during 
the exercise signifying that WBV was effective in providing a cardiovascular stimulus in 
this population. A study evaluating the benefits of a 12-week, 5 times weekly, WBV 
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protocol at 30Hz for 5 minutes each day was done on individuals living with paraplegia 
who regularly participated in sport (Melchiorri et aI., 2007). It was found that the average 
muscle force, velocity and power were increased in the upper limbs following the 12-
week protocol whereas body composition and bone mineral density did not change. 
2.6.3 Benefits of an Acute Bout ofWBV 
The mechanical stimulation induced by the vibration on the platform has been 
shown to have positive acute effects. Whole-body vibration has been used on the able-
bodied population to test the effects on cardiovascular outcomes. For example, Rittweger 
and colleagues (2001) have shown that vibration groups have a greater V02 peak than 
none-vibration controls. Conversely, another study found that V02 only increased when a 
lendrassik maneuver (participant pulled with both arms on a dual-handle load cell) was 
performed in concert with the vibration. This is due to the summation of the stretch reflex 
excitation caused by the WBV and the excitation already placed on alpha motor neurons 
due to the lendrassik maneuver. As such, it was concluded that WBV alone may not be a 
sufficient stimulus to elicit changes in cardiovascular fitness (Cochrane et al., 2008). 
Yamada and colleagues (2005) found that WBV reduces muscle oxygenation levels 
compared to those without WBV. The contracting of the muscles, caused by the 
vibration, placed demands on the circulatory system for increased blood flow and 
therefore, it was concluded that WBV may be an efficient training stimulus. Mester et al. 
(2006) found that total peripheral resistance (TPR) and mean arterial pressure increased 
significantly during vibration with no change in cardiac output. To account for this 
increase in TPR, it was postulated that the vibration caused vessel deformation. 
Immediately after vibration, TPR dropped 25% below baseline levels and mean blood 
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pressure dropped 29% below baseline values. These adaptations were attributed to the 
opening of more capillaries or the dilation of some blood vessels in order to facilitate 
efficient gas and material metabolism between blood vessels and muscle fibres. 
In the able-bodied population, one study has investigated the direct effect of 
WBV on arterial compliance using PWV as the experimental measure. Otsuki and 
colleagues (2008) assessed arterial compliance measuring brachial-ankle PWV in 10 
healthy men pre-WBV as well as 20, 40 and 60 minutes after an acute bout ofWBV. The 
protocol included a set vibration frequency of 26Hz, with intermittent vibration (60s on 
and 60s off) with the participants positioned in a static squat. The results showed that in 
the WBV group, the brachial-ankle PWV value significantly decreased denoting an 
increase in arterial compliance, at 20 and 40 minutes after the trial without any significant 
decrease in blood pressure. Also important to note, as previously mentioned, individuals 
with SCI have a risk for postural hypotension. The results from Otsuki and colleagues 
(2008) showed no reduction in blood pressure during WBV and therefore, this form of 
exercise was not associated with an increased risk for postural hypotension within this 
population. The mechanisms underlying the acute exercise-induced increase of arterial 
compliance may be related to the mechanical stimuli of the vibration causing a 
deformation of the endothelial cells, resulting in the release of NO and vasodilatation 
(Otsuki et al., 2008). 
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Chapter 3: Inter- and Intra-Observer Reliability for PWV in Individuals with SCI 
3.1 Methods of Assessing PWV Inter- and Intra-Observer Reliability in Individuals 
with SCI 
The participants recruited for this reliability study, were recruited from the 
Lyndhurst Centre in Toronto, Ontario, and were the same participants that were involved 
in the acute WBV study described in Chapter 4 of this thesis. For inclusion into the study, 
participants had to be: male, between the ages of 20-60 years of age at the 
commencement of baseline measures, living with long-term SCI (C1 to T12, AIS A to E; 
over 1 year post-injury), having sustained the injury by traumatic etiology (motor vehicle 
accident, fall, sports injury, violence, etc). Refer to Appendix C for the Standard 
Neurological Classification of Spinal Cord Injury. 
Participants were required to abstain from caffeine, nicotine and alcohol for 12 
hours and to fast for a minimum of 6 hours prior to testing. For medications that were 
required to be taken with food, the participants were permitted water and up to one slice 
of bread. Participants were also asked to not partake in vigorous exercise for the 12 hours 
preceding the measurements. 
Two identical Smartdop50 transcutaneous Doppler flowmeters (Hadeco, Inc., 
Kanagawa, Japan) were used and placed at the vascular landmarks on each participant to 
obtain a pair of measurements. The PWV measurement was taken at the aortic pathway. 
Transcutaneous flow waves were recorded with the use of Doppler flowmeters, and beat-
by-beat data were visualized and recorded via Chart 5.2 software and a PowerLab/16SP 
data acquisition system (AD Instruments , Inc. Bella Vista, Australia). 
The distance traveled by the pulse waveform was assessed by the measurement of 
the distance between two vascular landmarks over the surface of the body using a non-
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elastic tape measure. Measurements of PWV were taken along the aorta (common carotid 
at the neck to the common femoral artery at the inguinal crease in thigh). The 
measurements were taken following 20 minutes of supine rest. PWV was calculated from 
this distance divided by the average of at least 20 wave latencies in cm/sec. Transit time 
was determined from the time delay between the proximal foot and the distal foot of the 
waveform (Figure 1). It is important to note that only the reliability of the data analysis 
was being conducted in this study, rather than the reliability of the PWV test (which 
would entail data collection and analysis). Thus, PWV measures were only conducted 
once, but analyzed twice, and the reliability of the analysis only was subsequently 
evaluated. 
The data chosen for analysis was baseline aortic PWV values, and an intraclass 
correlation test was performed to determine whether a significant relationship existed 
between and within the testers. In addition, a Bland-Altman plot was used to determine if 
the magnitude of the baseline PWV had any bearing on its degree of reliability (Bland & 
Altman, 1986). Significance was set at p~0.05, and all values are expressed as means ± 
standard deviation (SD). 
3.2 Results of Inter- and Intra-Observer Reliability Testing for PWV in Individuals 
with SCI 
A total of eight participants were included in the study. All participants were male 
with an average age of 41.8±10.7 years, a post-injury period of 11.0±8.4 years, a weight 
of79.9±19.6 kg and height of 174.3±6.3 cm. Based on the initial neurological 
examination provided by the American Spinal Injury Association (ASIA), five 
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A B 
Figure 1: A) represents the blood pressure waves of aortic PWV, the red is the femoral artery and blue is posterior 
tibial artery. B) represents the zoomed view of the same highlighted blood pressure wave in A. The boxes represent the 
point on the wave when the systolic upstroke is beginning. The transit time is difference in time between these two 
points. Time (s) is on the X axis. 
participants were classified as having a complete injury (ASIA Impairment Scale A; AIS 
A) and three as having an incomplete injury (AIS D). Lesions levels ranged from C4 to 
TIL 
Observer 1 found an average baseline aortic PWV value of 946.0±I36.4 cmls and 
Observer 2 found an average of 927.0±I72.2 cmls (Table 1). The intraclass correlation 
analysis calculated the coefficient to be 0.76 (p=0.006). Figure 2 shows the Bland-
Altman plot for this data. The points in this graph show no skewness, and therefore, the 
difference between observer analysis is not dependent on the mean. 
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Table 2 shows the intra-observer reliability. Analysis 1 calculated an average 
baseline aortic PWV value of 946.0±136.4 cmls while on analysis 2, an average baseline 
aortic PWV valueof954.0±128.6 cmls was calculated. The intrac1ass correlation 
coefficient was very high (r=O.93, p<O.OOl). Figure 3 shows the Bland-Altman plot for 
this data. The points in this graph show no skewness, and therefore, once again, the 
difference of intra-observer analysis is not dependent on the mean. 
Table 1: PWV values (cm/s) for both observer 1 and observer 2. 
Participant PWV value for Observer 1 PWV value for Observer 2 
(cmls) (cmls) 
1 875 848 
2 851 825 
3 1044 991 
4 948 1201 
5 815 771 
6 902 811 
7 894 803 
8 1237 1169 
Mean 946 927 
SD 136.4 172.2 
Table 2: PWV values (cm/s) for both analysis land analysis 2 of observer 1. 
Participant PWV value for Analysis 1 PWV value for Analysis 2 
(cmls) (cmls) 
1 875 822 
2 851 833 
3 1044 1082 
4 948 997 
5 815 889 
6 902 948 
7 894 871 
8 1237 1187 
Mean 946 954 
SD 136.4 128.6 
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Figure 2: Bland-Altman plot for the inter-observer reliability for aortic PWV values showing observer 1 -
observer 2 plotted against the mean of observer 1 and observer 2 values (cm/s). 
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Figure 3: Bland-Altman plot for the intra-observer reliability for aortic PWV values showing analysis 1 -
analysis 2 plotted against the mean of analysis 1 and analysis 2 values (cm/s). 
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Chapter 4 - The Effect(s) of Whole Body Vibration on Pulse Wave Velocity in 
Individuals with SCI 
4.1 Methods 
4.1.1 Participant Information 
4.1.1.1 Participant Recruitment 
The participants for the current study were recruited through the Lyndhurst Centre 
in Toronto, Ontario, Canada. The methods of recruitment included poster campaigns, 
referral by a rehab service provider, at the individual's request, or with the use of the SCI 
Long-term Follow-up database which contains a list of individuals interested in rmding 
out more information about ongoing SCI research at the Lyndhurst Centre. 
4.1.1.2 Participant Screening 
Potential participants were asked to complete a telephone pre-screening interview 
to ensure that they did not have a prior history inconsistent with safe WBV. The 
telephone screening consisted of obtaining verbal consent to collect health and 
demographic information about the participant in order to determine the first stage of 
eligibility. This information included age, weight, height, traumatic/non-traumatic SCI, 
medical history and concomitant medications. Following the completion of a successful 
pre-screening process, a Letter of Introduction and Consent Form was mailed to each 
participant. These forms were reviewed by the participant prior to the screening visit. It 
was during this subsequent screening visit that written informed consent from the 
participant was obtained prior to conducting any study-related testing or evaluation. The 
screening visit began with the collection of written, informed consent in order to allow 
participation in the study. Any changes to the potential participant's medical history or 
medications since pre-screening were recorded. Once these were completed, a physical 
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examination, medical history, a blood test screening for anemia and vitamin D 
deficiency, an ultrasound of the kidney and bladder to rule out stones, and an X -ray of the 
spine for the assessment of hardware were completed by a trained physician. 
4.1.1.3 Participant Inclusion and Exclusion Criteria 
Prior to data collection, potential participants were required to meet inclusion and 
exclusion criteria. This information was gathered through the telephone interview and 
was reviewed and verified with their medical records and medical history during the 
screening visit. 
The inclusion criteria for this study included: male participants between the ages 
of 20-60 years of age at the commencement of baseline measures; individuals living with 
long-term SCI (CI to T12, AIS A to E; over I year post-injury) who sustained the injury 
by traumatic etiology (motor vehicle accident, fall, sports injury, violence, etc). Refer to 
Appendix C for the Standard Neurological Classification of Spinal Cord Injury. 
The exclusion criterion included individuals with a height of less than 168cm or 
greater than 188cm. This height restriction was in place for safety as the vibration 
platform is only able to accommodate individuals within this specific range. Individuals 
with a history of uncontrolled autonomic dysreflexia, untreated orthostatic hypotension, 
seizure disorder, frequent migraine headaches, rheumatoid arthritis, current kidney 
stones, arrhythmias, valvular heart disease, non-union fragility fracture, dislocated hip, 
cochlear implants, DVT, spondylolisthesis, diabetes, gallstones, pacemaker, cancer or 
lower extremity pressure ulcer were excluded as these conditions may cause WBV 
exposure to be unsafe. In addition, participants with conditions which might make it 
difficult to stand safely in the standing frame such as combined hip and knee flexion 
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contractures of >30°, plantar flexion contractures of >20°, or bilateral heterotrophic 
ossification of the hip or knee region were excluded. Individuals were also excluded if 
they were concurrently participating in another intervention study or program that might 
confound interpretation of the study results. As well, individuals were excluded if they 
were unable to pass the postural retraining protocol, had anemia or vitamin D deficiency 
or the presence of kidney or bladder stones within 6 months of enrolment. 
4.1.1.4 Postural Retraining Protocol 
Following the screening visit, the participants were asked to perform a postural 
retraining protocol (PRP) prior to the WBV protocol (Appendix A). Each participant was 
required to complete the training within five sessions or they were excluded. Postural 
retraining employs a tilt to the individual on a tilt table, and if successful, helps the 
individual to better accommodate to changes in vertical position (as in going from sitting 
to standing) without undue hypotension or syncope. The PRP was deemed complete once 
the participant was able to tolerate going from a seated position to a near erect posture 
(85° tilt) and remain in the near erect posture for 30 minutes without symptoms of 
orthostatic hypotension. Figure (4) shows a time line of the recruitment process. 
4.1.1.5 Participants o/the Current Study 
A total of eight (n=8) participants were included in the study. All participants 
were male with an average age of 41.8±10.7 years, a post-injury period of 11.0±8.4 years, 
a weight of79.9±19.6 kg and height of 174.3±6.3 cm. Based on the initial neurological 
examination provided by the American Spinal Injury Association (ASIA), five 
participants were classified as having a complete injury (ASIA Impairment Scale A; AIS 
A) and three as having an incomplete injury (AIS D). Lesions levels ranged from C4 to 
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T1l. See Table 1 for participant characteristics. It is also importantto note that during 
this study, no adverse events including orthostatic intolerance, autonomic dysreflexia or 
pressure sore development were observed. 
Table 3: Participant Characteristics. 
Participant Level of ASIA Age Time Post Height Weight 
Injury Level (years) Injury (years) (cm) (kg) 
1 C4 D 36 13.2 173.0 73.2 
2 Tll D 44 25.6 178.0 72.7 
3 T10 A 53 8.6 173.5 82.3 
4 T6 A 34 6.8 176.0 58.2 
5 T6 A 42 20.9 169.0 105 
6 T8 D 43 1.1 187.4 109.1 
7 T4 A 24 7.5 · 168.0 55.0 
8 T3 A 58 4.4 169.5 84.1 
4.1.2 Acute Whole-Body Vibration Protocol 
4.1.2.1 Experimental Timeline 
The purpose of this study was to determine the acute effect( s) of WBV on arterial 
compliance. A change in PWV was used to indicate a change in arterial compliance. 
After initial screening and the PRP, a passive stance (PS) protocol was performed. The 
PS protocol acted as a control for the possible changes in PWV resulting from assuming 
the upright position. The WBV protocol was implemented approximately 1 week 
following the completion of the PS protocol. Refer to Figure 4 for timeline of the 
screening and training protocols. 
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Figure 4: Timeline of Participant Recruitment and Protocol 
4.1.2.2 Passive Stance Protocol 
The purpose of the PS test was to control for the possible effects of the upright 
position when testing for the effects of WBV on arterial compliance. All of the PS 
sessions were performed at the Lyndhurst Centre. On this day, the participants entered 
the lab, transferred onto a bed and rested for 20 minutes in a supine position. Supine 
PWV measurements of the arm (brachial to radial artery), aorta (common carotid to 
femoral artery) and leg (femoral to posterior tibial artery) were taken in a random order. 
These measurements acted as the baseline values to compare to the values following the 
passive stance protocol. During the PS protocol, participants were elevated to a near 
complete upright position with knee flexion of 160° (full knee extension = 180°). The 
elevation to the upright position was controlled by the participant using the Easy Stand 
5000 (Easystand, Minnesota, USA), and took approximately 1-2 minutes, to avoid a 
dramatic decline in blood pressure. The participants' thighs and calves were supported by 
cushions to maintain knee flexion and extra support for balance was allowed by leaning 
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on a shelf at the front of the apparatus. Prior to beginning passive stance, the participants 
were asked to void their bladder and bowels. In addition, an abdominal binder was placed 
on the participant prior to elevation to help prevent orthostatic hypotension· and extra gel 
cushions were placed at the knees and lumbar spine to prevent pressure sore formation. 
The participants remained in this PS position for a total of 45 minutes. At 30 minutes, the 
participants were lowered back to a sitting position to check pressure areas such as the 
knee and lumbar spine, using the blanching technique, to detect any new skin irritations. 
If the circulation remained adequate to prevent such irritations, the participant was 
elevated back to the upright position to complete the final 15 minutes. Following the 
completion of the 45 minutes of passive stance, the participants were returned to the 
supine position. PWV measurements of the three sites were then completed at 10 minutes 
following the passive stance. 
Blood pressure (BP), as measured by manual auscultation and heart rate (HR), as 
measured by a heart rate monitor (Polar, New York, USA) were carefully monitored 
throughout the entire protocol to ensure safety for the participant. Blood pressure and HR 
were first taken after the 20-minute rest period to ensure no adverse events prior to 
commencing any testing. Blood pressure and HR were measured again in the seated and 
upright positions to ensure that there were no signs of orthostatic hypotension, and then 
again at I5-minute intervals during the passive stance protocol. Lastly, BP and HR were 
monitored again after 5 minutes in the supine position upon completion of the passive 
stance protocol. Blood pressure was converted to mean arterial pressure (MAP) for 
analysis. The equation used was MAP = 2/3(diasto1ic pressure) + 1I3(systo1ic pressure). 
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4.1.2.3 WBV Protocol 
The WBV training protocol consisted of a 45-minute session one week following 
the passive stance protocol. All of the sessions were performed at the Lyndhurst Centre. 
The protocol of WBV is as described for the passive stance with the addition of the WBV 
while standing on the platform. Each participant was exposed to intermittent 45Hz 
vibration with a displacement of 0.6mm on a modified W A VE® platform (WAVE 
Manufacturing Inc, Ontario, Canada). Refer to Appendix E for visual representations of 
the apparatus. Each intermittent vibration cycle consisted of 60 seconds of vibration 
followed by 120 seconds of no vibration. These cycles alternated for a total of 15 minutes 
and 3 sets for a total of 45 minutes. At the end of each set, BP and HR were measured 
and after 30 minutes, the skin circulation at the knees was checked as in PS. In addition, 
to reduce the risk of autonomic dysrefexia during PS and WBV, the participants were 
asked to empty their bowel and bladder. As well, to prevent orthostatic hypotension, an 
abdominal binder was placed on the participant prior to both protocols. Participants were 
monitored for and were asked to report any signs and symptoms of autonomic dysreflexia 
and BP was monitored to detect potential episodes of autonomic dysreflexia. 
4.1.3 Experimental Measures 
4.1.3.1 Pulse Wave Velocity 
Pulse wave velocity was chosen as the assessment tool for arterial compliance due 
to its association with cardiac events (Abhayaratna et aI., 2008) and its relationship with 
other cardiovascular risk factors (Taquet et al., 1993). In addition, as stated in Chapter 3, 
PWV has high inter- and intra-observer reliability and therefore can be used with 
confidence for the assessment of arterial compliance. The PWV measurement technique 
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was identical to that described in Section 3.1 (p. 47-48). However, in this protocol, PWV 
measurements were taken at the arm (brachial artery at inner arm to radial artery at the 
wrist), leg (common femoral at inguinal crease to posterior tibial artery posterior to 
lateral malleolus) and aortic (common carotid at the neck to common femoral artery) 
pathways. These sites were included to determine the effect of WBV exercise on arterial 
compliance in the central and peripheral vasculature as measured by PWV. 
4.1.4 Statistical Analysis 
Descriptive statistics were used to describe the participant's baseline demographic 
and impairment characteristics. A 2-way (condition by time) repeated measures ANOV A 
was used to detect potential changes in PWV evoked by WBV compared to passive 
stance. In addition, a I-way ANOV A was used to determine any significant differences 
between pre- and post- values for both PS and WBV trials. Other cofactors may account 
for any changes or lack of changes seen after WBV. Therefore, ten 2-way (condition by 
time) repeated measures ANCOV A calculations were performed per vessel measured to 
cofactor these variables. The variables included anthropometric measures (age, height, 
weight), injury characteristics (time post-injury), and cardiovascular measures (baseline 
PWV, baseline HR, change in HR from rest to WBV, baseline MAP, the change in MAP 
from rest to WBV and lastly, HR and MAP following WBV). Pearson r correlations were 
also performed on the same cofactors as the ANCOV A measurements to test possible 
relationships between these variables and potential changes in PWV after WBV. 
SCI specific characteristics are thought to affect the response to exercise. 
Therefore, in addition to performing the PWV analysis on the participants as a whole, the 
participant pool was divided into groups based on the level and severity of injury. The 
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level of injury was categorized as a neurological level either above or below T5. This 
threshold was chosen as the heart is sympathetically innervated by fibres originating from 
TI to T4 and therefore cardiac autonomic dysfunction is expected in injuries at and above 
this level. In addition, with injuries above T5, the splanchnic vascular bed which is 
innervated from T6-TI2, is at least partially disconnected from the vasomotor centre in 
the brain and there is vascular autonomic dysfunction with exercise. Thus, with SCI 
above T5, there is a reduced cardiac response as well as reduced vasoconstriction via the 
splanchnic nerves and therefore, a decreased ability of the heart and vessels to respond to 
exerCIse. 
For any given level of injury, a greater severity of injury is expected to worsen the 
ability of the heart and vessels to respond appropriately to exercise. In addition, WBV is 
j 
thought to recruit muscle fibers for increased muscle contraction activity via the tonic I 
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vibration reflex (TVR). The TVR excitation of the motor neurons may summate with the 
other excitatory input on the motor neurons producing a larger and stronger muscle 
contraction. As such, the WBV may result in a stronger muscle activation response with 
lower level and incomplete SCI. With the increased muscle firing there is the potential 
for an increased cardiovascular conditioning effect. Thus, the effects of WBV on PWV 
were also determined separately for those with complete (AIS A) and incomplete (AIS D) 
SCI. 
Therefore, participants were grouped based on level and severity of injury and a 
2-way (condition by time) repeated ANOV A was used to detect potential changes in 
PWV evoked by WBV compared to passive stance within these groups. In addition, a 1-
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way ANOV A was conducted to determine any baseline PWV differences between the 
groups. 
Statistical significance was set at p:SO.05 and all values are expressed in means ± 
standard deviation (SD). Effect sizes were also calculated to determine whether our 
sample size was sufficient to witness significant changes (Keppel & Zedeck, 1989). 
4.1.5 Safety and Caution Considerations 
4.1.5.1 Adverse Events 
All individuals were closely monitored for the development of any adverse 
responses. In particular, the adverse events that were closely monitored were orthostatic 
hypotension, autonomic dysreflexia and the effects of pressure on the skin. The testing 
was to be stopped immediately upon any event that was deemed to jeopardize the health 
of the participant. This decision was left to a physician who would evaluate the situation 
and determine if the protocol could continue or not. The protocol was to be resumed if 
I and when the same physician deemed it safe to do so. 
4.1.5.2 Orthostatic Hypotension 
For safety of each participant, blood pressure was measured at arrival, during 
quiet standing in the standing frame prior to vibration exposure, and at 15-minute 
intervals until the training session was complete. Changes in blood pressure between 
sitting, standing, and vibration were monitored, and if the participant showed signs of 
severe orthostatic hypotension between sitting and standing, the vibration was not 
commenced. If hypotension developed during the WBV, the WBV was stopped. Severe 
orthostatic hypotension was operationally defined as a drop in systolic blood pressure 
below 70mmHg, diastolic blood pressure below 40mmHg or heart rate below 50bpm. 
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4.1.5.3 Autonomic Dysrejlexia 
If a participant demonstrated signs of moderate autonomic dysreflexia, indicated 
by a rise of greater than 40mmHg in systolic blood pressure, the vibration session was to 
be stopped and the subject monitored until symptoms resolved. The subject was to be 
transferred to a monitored setting if the autonomic dysreflexia was severe or persisted. 
Signs and symptoms included sweating above the lesion, a flushed face, and a pounding 
headache in addition to the rise in blood pressure. 
4.1.5.4 Pressure Sores 
Pressure sores were monitored using the NPUAP grading scale (Appendix B). 
Because there was potential for participants to develop anterior knee-region pressure 
sores and pressure areas on the bony prominences of the sacrum and coccyx with the PS 
and WBV protocols, precautions were taken with the gel cushion. If a participant's skin 
was at risk during the PS or WBV as determined by the blanching technique, the testing 
was to be terminated. 
4.2 Results 
4.2.1 Pulse Wave Velocity 
4.2.1.1 All Participants 
Three separate 2-way repeated measures ANDV A's were used to determine 
whether there was a condition by time interaction when examining PWV in the aorta, leg 
and arm. There was no significant interaction found for either the aorta (p=O.64, Figure 
5), leg (p=O.80, Figure 6) or arm PWV (p=O.92, Figure 7). A I-way ANDV A was then 
performed to determine whether PS or WBV had a significant effect on PWV. In 
addition, effect sizes (ES) were calculated to determine whether our sample size was 
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sufficient to witness significant changes. Following PS, there was no significant change 
in PWV along the aorta (946.2±136.6 vs. 936.3±185.4 cmls, p=0.73, ES=O.II) or the arm 
(1101.8±154.8 vs. 1170.2±197.5 cmls, p=0.21, ES=0.25). However, leg PWV did show a 
significant 7.1 % increase (1025.4±76.1 vs. 1098.0±94.7 cmls, p=O.05, ES=O.39). One-
way ANOV A showed no significant changes in PWV following WBV (aorta: 
928.6±127.7 vs. 901.1±96.6 cmls, p=0.12, ES=0.12; leg: 1035.2±113.8 vs. 1099.8±114.2 
cmls, p=0.11, ES=0.27; arm: 1118.9±119.8 vs. 1181.1±124.40 cmls, p=O.28, ES=0.25). 
4.2.1.2 Level o/Injury 
Three participants were classified with injuries above T5 and five participants 
below T5. In individuals with an injury above T5, there was no significant condition by 
time interaction for aortic PWV (pre-PS: 1002.0±203.7 vs. post-PS 1048.3±271.1 cmls; 
pre-WBV: 1005.3±180.6 vs. post-WBV: 934.7±155.0 cmls, respectively, p=0.17, Figure 
8). There was also no significant condition by time interaction for aortic PWV in 
individuals with injuries below T5 (pre-PS: 912.0±89.4 vs. post-PS: 869.2±91.4 cmls; 
pre-WBV: 881.4±70.8 vs. post-WBV: 880.2±53.9 cmls, p=O.14, Figure 9). 
In individuals with an injury above T5, there was no significant condition by time 
interaction for leg PWV (pre-PS: 1059.3±70.9 vs. post-PS: 1110.3±38.9 cmls; pre-WBV: 
972.3±45.8 vs. post-WBV: 1088.3±97.4 cmls, p=0.50, Figure 10), however, for 
individuals with injuries below T5, there was a trend for a condition by time interaction 
for leg PWV following WBV compared to PS (pre-PS: 1004.0±78.7 vs. post-PS: 
1090.0±121.5 cmls; pre-WBV: 1072.8±129.9 vs. post-WBV: 1104.6±134.0 cmls, p=0.06, 
Figure 12). That is, the increase observed in leg PWV was less after WBV than with PS. 
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In individuals with an injury above T5, there was no significant condition by time 
interaction for arm PWV following WBV compared to PS (pre-PS: 1109.7±271.7 vs. 
post-PS: 1203.3±336.7 cm/s; pre-WBV: 1057.0±139.0 vs. post-WBV: l152.3±153.0 
cm/s, p=O.97, Figure 11). In addition, there was no significant condition by time 
interaction for arm PWV in individuals with injuries below T5 (pre-PS: 1095.4±70.2 vs. 
post-PS: 1149.4±101.1 cm/s; pre-WBV: 1155.2±104.6 vs. post-WBV: 1198.6±119.9 
cm/s, p=O.91, Figure 13). 
Three I-way ANOVA's were conducted to determine if any baseline differences 
existed between the groups before WBV. Aortic baseline PWV showed no significant 
differences (above T5: 1005.0±180.6 cm/s; below T5: 881.0±70.8 cm/s; ES=0.41; 
p=O.74; Figure 23) between the groups. However, trends were shown for leg (above T5: 
972.0±45.8 cm/s; below T5: 1073.0±130.0 cm/s; ES=0.46; p=O.07; Figure 24) and arm 
(above T5: 1057.0±139.6 cm/s; below T5: 1155.0±104.6 cmls; ES=O.37; p=O.06; Figure 
25) baseline PWV. Thus, leg and arm baseline PWV tended to be higher in individuals 
with injuries below T5. The effect sizes showed a moderate effect, and therefore 
statistical significance may have been achieved with greater sample size. 
4.2.1.3 Severity of Injury 
Three participants were classified with incomplete injuries and five participants 
with complete injuries. In individuals with complete injuries, there was no significant 
condition by time interaction for aortic PWV (pre-PS: 987.6±162.4 vs. post-PS: 
980.2±230.6 cm/s; pre-WBV: 940.8±155.l vs. post-WBV: 906.6±123.7 cmls, 
respectively, p=O.70, Figure 14). There was also no significant condition by time 
interaction for aortic PWV in individuals with incomplete injuries (pre-PS: 876.0±25.5 
56 
vs. post-PS: 863.3±33.5 cm/s; pre-WBV: 906.3±88.6 vs. post-WBV: 890.7±42.1 cm/s, 
p=O.20, Figure 15). 
In individuals with complete injuries, there was no significant condition by time 
interaction for leg PWV (pre-PS: 1037.8±79.6 vs. post-PS: 1064.4±1064.4 cm/s; pre-
WBV: 1090.8±95.2 vs. post-PWV: 1141.2±120.7 cmls, p=O.67, Figure 16). As well, in 
individuals with incomplete injuries there was no significant condition by time 
interaction for leg PWV following WBV compared to PS (pre-PS: 1003.0±80.5 vs. post-
PS: 1153.0±35.0 cm/s; pre-WBV: 942.3±81.1 vs. post-WBV: 1027.3±66.0 cm/s, p=0.20, 
Figure 18). 
In individuals with complete injuries, there was no significant condition by time 
interaction for arm PWV (pre-PS: 1165.8±142.1 vs. post-PS: 1180.6±238.9 cm/s; pre-
WBV: 1179.2±78.9 vs. post-WBV: 1205.0±126.2 cm/s, p=O.91, Figure 17). In addition, 
there was also no significant condition by time interaction for arm PWV in individuals 
with incomplete injuries (pre-PS: 992.3±123.6 vs. post-PS: 1151.3±146.6 cm/s; pre-
WBV: 1017.0±114.6 vs. post-WBV: 1141.7±136.3 cm/s, p=0.21, Figure 19). 
Three I-way ANOVA's were calculated to determine if any baseline differences 
existed between the groups before WBV. Neither aortic (complete: 941.0±155.1; 
incomplete: 906.0±88.6 cm/s; ES=O.13; p=0.20; Figure 26), leg (complete: 1091.0±95.2; 
incomplete: 942.0±81.1 cm/s; ES=O.64; p=O.26; Figure 27) nor arm (complete: 
1179.0±78.9; incomplete: 1017.0±114.6 cmls; ES=O.64; p=0.29; Figure 28) baseline 
PWV were significantly different between the groups. The effect sizes for the leg and 
arm are considered a large. Therefore, with more participants, a significant difference in 
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baseline PWV at the leg and arm may have been achieved when comparing those with 
complete and incomplete SCI. 
4.2.1.4 Accounting for Other Cofactors 
Ten potential cofactors were examined to see if the lack of significant changes in 
PWV following WBV were due to any cofounding variables. These cofactors included 
anthropometric measures (age, height, weight), injury characteristics (time post-injury), 
and cardiovascular measures (baseline PWV, baseline HR, change in HR from rest to 
WBV, baseline MAP, the change in MAP from rest to WBV and lastly, HR and MAP 
following WBV). None of the variables tested were found to be significant cofactors as 
determined by 2-way repeated measures ANCOV A calculations. Refer to Tables 6-9 in 
Appendix D for ANCOV A tables and Figures 20-22 for the baseline PWV co-factor 
graphs. 
4.2.1.5 Correlations 
Pearson's r correlations were conducted to test whether the same cofactors used in 
the ANCOV A measurements correlated with the changes in PWV after WBV. A trend 
was found for time post-injury and the change in aorticPWV after WBV (r=0.68, 
p=0.07) such that, the more acute the injury, the greater the decrease in PWV after WBV. 
Refer to Table 10 and 11 in Appendix D for correlation coefficients and p values for all 
correlations. 
4.2.2 Mean Arterial Pressure and Heart Rate 
Table 5 in Appendix D shows the pre and post values for MAP and HR following 
PS and WBV. There was no condition by time interaction for either MAP or HR as 
58 
. I 
I 
I 
determined by 2-way repeated measures ANOV A. Further, a I-way ANOV A showed no 
change in MAP following PS (99.1±14.1 to 96.l±6.8, p=O.46) but a trend for an increase 
in HR (63.4±7.8 to 66.8±7.2 bpm, p=O.07). Similarly, a I-way ANOVA showed no 
change in either MAP (98.3±16.4 to 98.1±14.9, p=0.35) or HR (66.6±7.9 to 64.1±7.4 
bpm, p=0.23) following WBV. 
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Chapter 5: Discussion 
5.1 Major Findings 
The main finding of the current study is that WBV, when compared to PS without 
vibration, did not cause a change in aortic, leg or arm PWV in individuals with SCI. A 
second major finding is the demonstration that measuring aortic PWV in people with SCI 
has a high intra- and inter-observer reliability and therefore can be used with confidence 
when assessing arterial compliance. 
Furthermore, when grouped based on level and severity of injury, there were no 
differences found when comparing PWV after WBV and PS. However there was a trend 
for those with SCI below T5 to have the leg PWV rise seen in PS attenuated with the 
addition ofWBV. There was a trend for a positive correlation that showed that the shorter 
the time post-injury, the greater the decrease in PWV. 
Many studies have shown that people with SCI have an increased risk for 
cardiovascular disease (DeVivo et aI., 1999; Krassioukov et aI., 2003). Miyatani et aI., 
(2009) demonstrated that PWV, an index of arterial stiffness, is increased in people with 
SCI, and this increased stiffness, or reduced arterial compliance, has been reported to be 
an independent cardiovascular risk factor (Arnett et aI., 1994). Exercise has been shown 
to improve arterial compliance and improve cardiovascular conditioning in the able-
bodied population (Vaitkevicius et aI., 1993; Tanaka et aI., 2000; Otsuki et aI., 2007; 
Heffernan et aI., 2007; Maeda et aI., 2008). As there are many challenges for exercise in 
individuals with SCI, other modalities have been investigated in an effort to improve their 
cardiovascular health. Both acute and long-term WBV, have been shown to have a 
positive effect on both muscle strength (Mester et aI., 2006; Roelants et aI., 2007; 
60 
Bogaerts et aI., 2009) and cardiac conditioning in the able-bodied population (Rittweger 
et aI., 2001, Yamada et aI., 2008). Furthermore, a study by Otsuki et aI., (2008) 
demonstrated a reduction ofPWV in able-bodied individuals after an acute bout ofWBV. 
The current study aimed to investigate if an acute session of WBV would reduce the 
PWV in people with SCI. 
The current study was the first to examine the effects of an acute bout of WBV on 
PWV in individuals with SCI with the hypothesis that there would be a reduction in PWV 
and improved arterial compliance after the acute bout ofWBV. However, after the acute 
bout of WBV, no change was observed in the aorta, leg or arm PWV in all the 
participants regardless of the level or severity of injury. The response to an acute bout of 
WBV varied highly between participants, and characteristics specific to SCI did not have 
a significant influence on the effects ofWBV. These results were not anticipated and 
were in contrast to the study of Otsuki et ai. (2008). 
There are several possible factors that may explain the lack of expected outcomes 
in this study. The mechanisms are related to the specific characteristics of the individuals 
with SCI well as several methodological parameters. 
The reduced effects of the WBV may be related specifically to the spinal cord 
injury. One mechanism for the reduction ofPWV by WBV is thought to be through the 
exercise conditioning effect of the muscle contractions induced by the tonic vibration 
reflex (Rittweger, 2010). In people with SCI above T5 there is disruption of the 
sympathetic nervous system and consequent reduced cardiac response to meet the 
demands of increased muscle work (Teasel et aI., 2000). This would be a potential 
explanation of the lack of response in the higher level SCI individuals. However, there 
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was no effect of WBV regardless of level of injury and another explanation is needed. It 
is thought that the tonic vibration reflex acts via the stretch reflex of the muscle spindles 
(Rittweger, 2010). After a SCI there is muscle atrophy with shortening and changes in 
composition of the muscle fibers and spindles. This may cause a reduced sensitivity for 
the muscle spindles to fire. As a result there is the potential for less spindle firing and 
muscle contraction response to the vibration. Thus, individuals with SCI may have a 
smaller muscle contraction response with less of a cardiac exercise-induced conditioning 
effect. As well, with reduced muscle contraction activation from the TVR there will be a 
reduced increase in local blood flow in the muscles, a reduced vessel wall deformation 
and reduced increase in limb vessel compliance. 
The lack of reduction in PWV in both individuals with complete or incomplete 
injuries may be related to the lack of background muscle activity needed for the 
summation with the TVR to produce significant muscle contractions. In Otsuki et al. 
(2008), the participants were in a static squat on the vibrating platform. This is to say that 
they were actively standing in a posture against gravity that demanded muscle activity to 
maintain the position. The participants in the present study, due to the nature of their 
injury, would have difficulty or would be incapable of performing a static squat, or 
indeed any active standing on their own. As a result of being held in a passive stance 
there was a lack of the background muscle activity that is required for the tonic vibration 
stretch reflex to summate with, and stimulate increased muscle activation. As mentioned 
in Cochrane et al. (2008), a lendrassik maneuver was necessary to activate the muscles 
prior to WBV to show any cardiovascular response. Therefore, passively standing during 
WBV, as in the current protocol, may have reduced the cardiovascular effect that has 
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been seen in the literature. As well, this lack of background muscle activity, which would 
have reduced the leg muscle contraction response, would potentially reduce the WBV 
effect on the leg arterial compliance changes. 
The strength of the vibration from the vibrating platform may also have been a 
limiting factor in the present study. As the vibration travels more proximally from the 
feet, the strength of the vibration is reduced (Rees et aI., 2008). In addition, the angle of 
knee and hip flexion are determining factors as to how high the vibration travels within 
the body (Rittweger, 2010). While standing fully erect, or nearly erect; with knees locked 
in extension, the vibration is transferred to the upper body, which may cause discomfort 
due to the shaking of the head and eyes (Rees et al., 2008). Therefore, with individuals 
being placed in a squatting position where the weight is posed on the forefoot, the 
resonance of the vibration is dissipated in the abdomen thus minimizing the discomfort 
individuals experienced (Rittweger, 2010). The present protocol required participants to 
stand with the knees at near full extension which may have permitted the vibration to 
travel up the body to the head. With the knees extended, it may have been more likely for 
the vibration-compression effect to act on the abdominal and thoracic aorta which, in 
turn, would increase the potential for aortic vessel deformation and improved 
compliance. However, due to the vibration effects on the head, the amplitude of the 
vibration was kept at 0.6 mm to reduce the discomfort. This amplitude was in contrast to 
the amplitude of Otsuki et al. (2008) which was 2-4mm. Therefore the strength of the 
vibration in this study may have been insufficient to attain the desired effect on the 
activation of the muscle contractions as well as on the shearing of the blood vessels. As 
such, there was not the expected increase in arterial compliance and reduced PWV. It is 
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of interest to note that there was a trend in the leg PWV change such that the increase 
seen in PWV following PS was reduced with the addition of the WBV. It is possible that 
the strength of the vibration in this study protocol with the knees extended was higher in 
the lower extremities than the strength of the vibration arriving at the aorta. As such, 
there was a lowering of the PWV with the WBV compared to the PS alone. 
5.2 Clinical Significance 
As the present results indicate, PWV did not change following acute WBV. As 
such, it may not be a feasible method for reducing arterial stiffness and consequently 
morbidity and mortality associated with CVD. However, several factors have been 
clearly indicated that may have played a role in the lack of significant findings. Because 
people with SCI have great difficulty engaging many forms of exercise, and have a high 
risk for CVD, it is imperative to consider certain modifications that can optimize WBV . 1 1 
before it is disregarded. 
Although there were no changes in the PWV after acute WBV, it would be 
worthwhile to investigate the long-term effects of WBV on PWV in people with SCI. As 
the conditioning effects of the muscle contractions are modest, they may accumulate over 
time if repeated and yield significant clinical value. As well, the repeated deformation of 
the vessels, although of small amplitude, may accrue over time and result in an increase 
in arterial compliance. Future studies of long-term WBV are needed to investigate its 
potential as a form of exercise for people with SCI. 
It may be useful to think of the clinical value ofWBV in the early adjustment 
period post-traumatic SCI. A trend was shown for a correlation between time post-injury 
and change in aortic PWV after WBV. The trend indicated that the more acute the injury, 
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the greater the decrease in PWV following WBV. This may indicate that ifWBV is 
introduced within the first year or so post-injury, when the muscle atrophy is less marked, 
it may confer a greater response in reducing PWV. As aortic PWV is an important 
indicator of arterial stiffness associated with cardiovascular morbidity, the 
implementation ofWBV as soon as medically permitted post-injury may help reduce the 
cardiovascular risk. 
As shown in the able-bodied population (Lehmann et al., 1992; Naidu et al., 
2005; Lee et al., 2009 and Frimodt-Moller et al., 2008), the current study showed a high 
intra-and inter-observer reliability for PWV analysis after SCI. As such, PWV can be 
confidently used as a tool for assessing aortic stiffness. The intra- and inter-observer 
reliability for PWV in individuals with SCI had never been tested. The current study 
showed that the inter-observer interclass correlation coefficient was 0.76 (p=0.006). 
According to Landis and Koch (1977), this correlation coefficient is 'good' as it falls 
between 0.60 and 0.81. The current study showed that the intra-observer interclass 
correlation coefficient was 0.93 (p<0.001). According to Landis and Koch (1977), this 
correlation coefficient is 'excellent' as it is above 0.81. The Bland-Altman graphs show 
that each point falls within ±2SD for inter- and intra-observer reliability. In addition, 
there is no skewness to the graphs meaning the difference between the observers and 
within observer, is not dependent on the magnitude of the PWV value calculated. As 
such, and similarly to the able-bodied population, PWV can be reliably analyzed both 
within and between testers for the SCI population. 
5.3 Limitations 
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Certain limitations existed in the current study. First, due to the paralysis that 
accompanies SCI, a standing apparatus was necessary in order for the participants to be 
upright on the vibrating platform for the duration of the protocol. The participants had a 
portion of their weight on a back seat (in addition to the heels of their feet) and therefore 
the use of the standing frame provided full support for a passive stance and there was no 
active muscle contraction performed by the participants. 
Secondly, the participants were lifted to a knee angle of 160°, whereas 180° is full 
knee extension. As previously mentioned, the closer the knee is to full extension, the 
more discomfort the participant experiences due to the transmission of the vibration to 
the head. In fact, several participants did complain of bothersome discomfort such as 
shaking and buzzing at the head. To alleviate this head shaking, participants tended to 
take more of their weight through their arms on the arm rest which may have reduced the 
vibration through the legs to the abdomen. Furthermore, the discomfort of transmission of 
the vibration up to the head may have been a factor that limited the amplitude of the 
vibration that could be tolerated, and therefore, the amplitude and frequency of vibration 
employed in the present study were different than those employed in Otsuki et al., 
(2008). 
Lastly, as individuals with SCI have different injury characteristics (ie. level and 
severity of injury) it is difficult to make group comparisons with a total population of 8 
participants. Trends were seen for a difference in baseline leg (p=0.07) and arm (p=O.06) 
PWV when comparing those with injuries above and below T5. That is, there was a trend 
for a higher baseline PWV in the arm and leg in those with an injury below T5. The 
effect size for this difference was moderate, and therefore increasing the sample size may 
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lead to statistical significance. This evidence combined with the lower rise in PWV in 
the leg after the WBV compared to the PS in the individuals with injuries below T5, may 
indicate that the WBV may have had a greater effect on the more stiffer. This finding 
gives some support to the value of WBV in improving arterial compliance. It is possible 
that with modifications in the protocol, and a larger and more homogeneous sample, the 
positive effect of WBV on reducing the PWV (and therefore increasing arterial 
compliance) would be observed. As well, we did not assess the activity habits of our 
participants. Individuals who are more physically active will have more conditioned 
muscles, which may ultimately have the potential for a stronger response to the stretch of 
the vibration. In addition, those who are more physically active will have a more 
conditioned cardiovascular system and may respond better to the vibration exercise. 
As seen in Maeda et ai., (2008), acute endurance exercise did not cause an increase in 
arterial compliance before training. However, after training, there was a significant 
increase in compliance following an acute bout of exercise. 
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· 1 
Chapter 6: Future Research and Conclusions 
6.1 Future Research 
This study was the first study to investigate the acute effect of WBV on arterial 
stiffness as assessed by PWV in individuals with SCI. For that reason, it may serve as a 
building block for many possible and exciting new research ideas that may benefit this 
vulnerable population. A long-term training protocol would be useful to determine 
whether WBV over a prolonged period of time will have a positive effect on arterial 
compliance. It would also be beneficial to have more homogenous groups and a large 
number of participants that would allow for a more thorough control of time post-injury, 
physical activity levels, the level and severity of injury, and lower limb strength. 
Increasing the participant pool for specific groups will help to distinguish which groups 
of individuals with SCI may benefit more from an acute and/or long-term protocol of 
WBV. 
Future research can also be conducted with a slightly refined methodology. First, 
it would be beneficial to have the participants undergo WBV with some knee flexion to 
reduce the vibrations from travelling up to the head. This would lessen the discomfort felt 
by the participants so that the more intense parameters of 26 Hz and 2mm amplitude, that 
has been used by others could be employed (Ostuki el al., 2008). Futhermore, there may 
be some benefit from increasing the "on" time duration of the vibration stimulation to 
provide a potentially greater strength of vibration stimulus on the muscles and vessels. 
The increased strength of the vibration stimulus would have the potential to more greatly 
affect vessel deformation and increase arterial compliance. 
Another protocol modification that may yield better results would be for the use 
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of a bodyweight support in conjunction with WBV so that the participants would be able 
to maintain as much of an active posture against gravity as possible. The WBV effects 
may be optimized as a result of more muscle recruitment during vibration. Furthermore, 
individuals with incomplete or complete injuries who are unable to stand on their own 
may benefit from performing a J endrassik maneuver for a general whole-body muscle 
excitation (at least to all the innervated muscles) which may confer a greater response to 
WBV. Increasing muscle activity during vibration may cause a higher muscle contraction 
strength response which in tum, may improve the general conditioning effect on the 
cardiac system and result in the reduced PWV of the vessels. 
6.2 Conclusions 
The present study was the first to examine the acute effect of WBV on PWV in 
individuals with SCI. The results showed that PWV was not changed following WBV 
and therefore WBV may not be an effective form of exercise to reduce the cardiovascular 
risk associated with increased arterial stiffness. It was also noted that neither baseline 
PWV, nor the change in PWV with WBV, varied based on the level or severity of injury. 
There may have been certain aspects of the protocol that may have contributed to the lack 
of change. Therefore, WBV must not be disregarded as a form of exercise intervention to 
help reduce the risk of CVD within this population. Rather, future studies with protocol 
modifications must be examined. 
This study was also the first to examine inter- and intra-observer reliability for 
PWV in individuals with SCI. The results showed that PWV is a reliable assessment tool 
and can be used with confidence in individuals with SCI. 
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Figure 5: Aortic PWV before and after PS and WBV in individuals with SCI. 
PWV values are expressed as means ± SD. Significance was set at p:SO.05. 
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Leg PWV following PS and WBV in Individuals with SCI. 
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Figure 6: Leg PWV before and after PS and WBV in individuals with SCI. 
PWV values are expressed as means ± SD. Significance was set at p:::;O.05 . 
* denotes significant change from pre- to post- PS as determined by I-way 
ANOVAonly. 
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Figure 7: Ann PWV before and after PS and WBV in individuals with SCI. 
PWV values are expressed as means ± SD. Significance was set at p~O.05. 
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Figure 8: Aortic PWV before and after PS and WBV in individuals with an injury 
above T5. PWV values are expressed as means ± SD. Significance was set at p::SO.05 . 
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Figure 9: Aortic PWV before and after PS and WBV in individuals with an injury 
below T5. PWV values are expressed as means ± SD. Significance was set at p:SO.05. 
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Figure 10: Leg PWV before and after PS and WBV in individuals with an injury 
above T5. PWV values are expressed as means ± SD. Significance was set at p::;O.05. 
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Figure 11: Arm PWV before and after PS and WBV in individuals with an injury 
above T5. PWV values are expressed as means ± SD. Significance was set at p~O.05. 
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Figure 12: Leg PWV before and after PS and WBV in individuals with an injury 
below T5. PWV values are expressed as means ± SD. Significance was set at p::SO.05. 
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Figure 13: Arm PWV before and after PS and WBV in individuals with an injury 
below T5. PWV values are expressed as means ± SD. Significance was set at p::;O.05. 
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Figure 14: Aortic PWV before and after PS and WBV in individuals with a complete 
injury. PWV values are expressed as means ± SD. Significance was set at p:::;O.05. 
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Figure 15: Aortic PWV before and after PS and WBV in individuals with an 
incomplete injury. PWV values are expressed as means ± SD. Significance was set 
at p::;O.05. 
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Figure 16: Leg PWV before and after PS and WBV in individuals with a complete 
injury. PWV values are expressed as means ± SD. Significance was set at p::;O.05. 
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Figure 17: Arm PWV before and after PS and WBV in individuals with a complete 
injury. PWV values are expressed means ± SD. Significance was set at p~O.05. 
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Figure 18: Leg PWV before and after PS and WBV in individuals with an incomplete 
injury. PWV values are expressed as means ± SD. Significance ,vas set at p:SO.05. 
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Figure 19: Arm PWV before and after PS and WBV in individuals with an incomplete 
injury. PWV values are expressed as means ± SD. Significance was set at p::SO.05 . 
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Figure 20: Aortic PWV before and after PS and WBV nonnalized for baseline 
PWV values in individuals with SCI. Values are expressed as a percent change 
from baseline value. Significance was set at p~O.05. 
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Figure 21: Leg PWV following PS and WBV normalized for baseline PWV 
values in individuals with SCI. Values are expressed as a percent change from 
baseline value. Significance was set at p:SO.05. 
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Figure 22: Arm PWV following PS and WBV normalized for baseline PWV 
values in individuals with SCI. Values are expressed as a percent change from 
baseline value. Significance was set at p~O.05. 
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Figure 23: Differences between baseline aortic PWV when grouped for injuries 
above or below T5. PWV values are expressed as means ± SD. Significance was set 
at p::SO.05. 
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Figure 24: Differences between baseline leg PWV when grouped for 
injuries above or below T5. PWV values are expressed as means ± SD. 
Significance was set at p:=SO.05. 
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Figure 25: Differences between baseline arm PWV when grouped for 
injuries above or below T5. PWV values are expressed as means ± SD. 
Significance was set at p~O.05. 
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Figure 26: Differences between baseline aortic PWV when grouped for 
complete or incomplete injuries. PWV values are expressed as means ± SD. 
Significance was set at p~O.05. 
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Figure 27: Differences between baseline leg PWV when grouped for complete or 
incomplete injuries. PWV values are expressed as means ± SD. Significance was 
set at p::;O.05. 
101 
1400 
1200 
u; 
E 1000 
~ 
~ 800 
D-
E 600 4( 
CD 
.5 
a; 400 
fI) 
ra 
m 
200 
0 
Baseline Arm PWV Grouped 
For Severity of Injury 
Colll>lete Incolll>lete 
Figure 28: Differences between baseline arm PWV when grouped for complete 
or incomplete injuries. PWV values are expressed as means ± SD. Significance 
was set at p:::;O.05 . 
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Appendix A: Postural Retraining Protocol 
Postural Retraining Protocol 
Stage I 
300 x 5 min 
HR,BP,PPS 
@3min 
intervals 
SBP< 70 mmHg 
DBP< 40 mmHg 
HR< 50 bpm 
PPS;;::3, 
Perceived Pre-Syncope Score CPPS) 
Sampson et al. (2000) 
'-------r--------"B 
Symptoms of syncope include light-headedness, 
dizziness, vision changes, nausea and fainting. 
o = no symptoms 
1 = mild symptoms 
2 = moderate symptoms 
3 = severe symptoms 
4= syllcope 
Stage II 
500 x 5 min 
HR,BP,PPS 
@3 min 
intervals 
SBP< 70 mmHg 
DBP<40mmHg 
HR < 50 bprn 
PPS ;;::3, 
or subj ect request 
Stage ill 
70° x 5 min 
HR,BP,PPS 
@3min 
intervals 
SBP< 70 mmHg 
DBP< 40 mmHg 
HR< 50bpm 
PPS;;::3, 
Stage IV 
85°x 30 min 
HR,BP,PPS 
@5min 
intervals 
SBP< 70 rnmHg 
DBP<40mmHg 
HR< 50 bprn 
PPS ;;::3, 
Maintain Stage IV until clinical end-
point is achieved (30 minutes at 85° 
without signs/symptoms of postural 
hypotension) or total time is 45 minutes 
1... ____ ....... P1.I_T_e_st_Terminated 
Note: First training session begins at Stage 1. If successive training sessions are needed, begin at the last completed stage 
(i.e., stage maintained for 15 minutes and PPS<2). The maximum number of training sessions is five. 
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Appendix B: Standard Neurological Classification of Spinal Cord Injury 
Patient Name _______________ _ 
Examiner Name ___________ ~ ___ _ Date/Time of Exam _______ _ 
STANDARD NEUROLOGICAL CLASSIFICATION 
OF SPINAL CORD INJURY 
ISC 
R L 
MOTOR 
KEY MUSCLES 
(SC()tiN,g (.w rs~<&rs¢ sf_de) 
C5 ' Wrist extenSO'S . C3 ~ Elbow flexors C2 C6 §. EfbO.W extenso. :~WJ. phalanx oJ rokklle finger) C4 C7 Finger flexdor~~rS(Tittiefioger) CS C8 ' FInger ab uc C6 
T1 C7 O+O~ c:J C8 UPPERUMB TOTAL 
(MAXIMUM) {2S} (25) (50} 
i.! T1 T2 
T3 
t:s
' ~
LIGHT 
TOUCH 
R L 
PIN 
PRICK 
R L 
Com,,",h . T5 
T6 ' ~I m I 
ro . ~ no I-......... n--I~ I m 
T121----l1--
L1 
L2 
L3 
L4 
SENiSORY 
KEY SENSORY POINTS 
1i~ /J I~~ . .~,-
L2 
L3 
L4 
L5 
S1 
§ Hip flexors L5 Knee extensors S 1 Ankle dorsiflexors S2 
"'onso", f--ll--i r-----1 Long toe 0 flexors 53 L..JL..J '---.J S Ankle plantar "",",,,,,,,,,, c:J S4-5y? 0 D-B ~ """"'">''' ''No,) I... " (Yes< , t = 
LO~~~A~M8 D + D=c:::J 
{MAXiMUMj (25) (1l5) (SO) 
N.EUROLOGICAL A L 
LEVEL SENSORVD 0 
7!>!;::~~~~;:;~~~~"'m MOTOR 0 0 
TOTALS{ D+S?««'-{~:-~~~~ 
(MAXIMUM) (56) (5 
COMPLETE OR JNCOMPLETE? 0 
1.~J1J~~re ;~ Ny 5tmSOry 01' In&ltw (W'~t~rtjn $4-.$5 
ASIA IMPAIRMENT SCALE 0 
PIN PRICK SCORE (max: 112) 
LIGHT TOUCH SCORE (max: 112) 
ZONE OF PARTIAL R L 
PRESERVATION SENSORY DO 
W.i'::;:~:':::!::":~:!Y MOTOR CJ CJ 
This form may be copied freely but should nol be alt(;red without permissfofl from the Amerk-,an Spir>allnjulY AssOCiation, 
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~'''' !) ~,=: •. 
• Key 
Sensory 
Points 
IlF.VO-"lliltl 
MUSCLE GRADING 
o total paralysis 
palpable or visible contraction 
2 active .Illovement, full range of 
motion, gravity eliminated 
3 active movement, full range of 
motion, against gravity 
4 active movement, full range of 
motion, against gravity and provides 
some resistance 
5 active movement, full range of 
motion, against gravity and provides 
normal resistance 
5* muscle able to exert, in examiner's 
judgement. sufficient resistance to be 
considered normal if identifiable 
inhibiting factors were not present 
NT not testable. Patient unable to reliably 
exert effort or muscle unavailable for test-
ing due to factors such as immobilization, 
pain on effort or contracture. 
ASIA IMPAIRl\tlENT SCALE 
D A = Complete: No motor or sensory 
thnction is preserved in the sacral 
segments 84-55. 
DB=. Incomplete: Sensory but not motor 
function is preserved below the 
neufologicallevel and includes the 
sacral segments 84-85. 
o C = Incomplete: Motor function is pre-
served below the neurological 
level, and morc than half of key 
muscles below the neurological 
level have a muscle grade less 
than 3. 
o D= incomplete: Motor function is pre-
served below the neurological 
level. and at least half of key mus-
cles below the neurologicallevcl 
have a muscle grade of 3 
or more. 
D E = Normal: Motor and sensory func-
tion are normal. 
CLINICAL SYNDROMES 
(OPTIONAL) 
D Central Cord 
o Brown-Scquard 
D Anterior Cord 
D Conus Medullaris 
D Cauda Equina 
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STEPS IN CLASSIFICATION 
The following order is recommended in determining the cla~sit1cation 
of individuals with SCI. 
1. Detennine sensory levels for right and left sides. 
2. Dctennine motor levels for dght and left sides. 
Note: in regions where there is no myotome to test, the motor level 
L~ presumed to be tIle same as the sensory level. 
3. Detennine the single neurological leveL 
This is the lowest segment where motor and sensmylunction is nOT-
mal on both sides, ami is the most cephalad (1f the sensory (md 
motor lc'pels determined in steps 1 and 2. 
4. Detennine whether the injury is Complete or Incomplete 
(sacral sparing). 
If voluntary anal contraction = No AND all S4-5 sensory scores = 0 
AND any anal sensation = No, then injury is COMPLETE. 
Otherwise injury is incomplete. 
5. Detennine ASIA Impainnent Scale (AIS) Grade: 
Is injury ~? If YES, AIS=A Record ZPP 
NO I 
Is injury t 
motor inepmp1ete? 
YES l 
{For ZPP record lowest dermatome or myotome on 
each side with some (non-zero score) preservation) 
IfNO,AIS=B 
(Yes=voluntary anal contraction OR motor 
function more than three levels below the motor 
level ana given side.) 
Are ~ half of the key .muscJes below the 
(single) neurologica.llevel graded 3 or better? 
NO J YES' 
AIS=C AIS=D 
If sensation and motor funmonis normal in all segments, AIS=E 
Note: AlS E is used in follow up testing when an individual with a 
documented SCT has recovered normal function. Tf at initial testing 
fW deficits are foun4. the individual is neurologically intat·t; tlte 
ASIA Impairment Scale does not apply. 
Appendix C: NPUAP Pressure Sore Rating Scale 
(Fowler et aL, 2008) 
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Appendix D: Raw Data 
Table 4: Pulse wave velocity values (cm/s) following PS and WBV measured at the aorta, leg and ann. * denotes a 
significant change (P:S0.05). 
PS WBV 
Aorta Leg Arm Aorta Leg Arm 
ParticiJ!ant Pre- Post- Pre- Post- Pre- Post Pre- Post- Pre- Post- Pre- Post 
1 875 878 978 1153 854 1001 997 938 921 1099 917 1066 
2 851 887 1093 1188 1092 1294 820 857 1032 1014 1142 1299 
3 1044 1020 1061 1205 1181 1037 996 974 1177 1312 1265 1221 
4 948 825 1019 1026 1150 1072 847 847 1197 1146 1152 1324 
5 815 789 909 913 1023 1185 842 846 1084 1082 1225 1089 
6 902 825 938 1118 1031 1159 902 877 874 969 992 1060 
7 894 906 1108 1077 1080 1017 829 778 987 1180 1195 1062 
8 1237 1361 1092 1101 1395 1592 1190 1088 1009 986 1059 1329 
Mean 946 936 1025* 1098* 1101 1170 928 901 1035 1099 1118 1181 
SD 136.0 185.3 76.1 94.7 154.8 197.5 127.6 96.5 113.8 114.2 119.8 124.4 
Table 5: MAP and HR values before and after PS and WBV 
Participant PS WBV 
Pre-MAP Post-MAP Pre-DR Post-DR Pre-MAP Post-MAP Pre-HR Post-HR 
(mmHg) (mmHg) (bpm) (bpm) (mmH~) (mmH~ (bpml (bpm) 
1 104.7 92.0 62.0 63.0 113.3 116.0 70.0 70.0 
2 95.3 102.0 65.0 68.0 91.3 92.0 68.0 60.0 
3 111.3 98.7 66.0 72.0 91.3 89.3 82.0 71.0 
4 77.3 89.3 68.0 68.0 98.0 98.7 61.0 60.0 
5 90.7 96.7 59.0 67.0 119.3 116.7 71.0 75.0 
6 80.0 89.3 55.0 53.0 69.3 73.3 62.0 54.0 
7 94.7 92.7 78.0 78.0 90.7 90.7 62.0 66.0 
8 120.0 108.7 54.0 65.0 113.3 108.0 57.0 57.0 
Mean 99.1 96.1 63.4 66.8 98.3 98.1 66.6 64.1 
SD 14.1 6.8 7.8 7.2 16.4 14.7 7.9 7.4 
Table 6: ANCOV A calculations for age, MPI, height and weight as cofactors for PWV after WBV. 
S' 'fi 005 Igm cance was set at p:S . 
Age MPI Height Weight 
p value p value p value p value 
Aorta 0.40 0.61 0.20 0.20 
Leg 0.15 0.81 0.10 0.30 
Arm 0.78 0.34 0.72 0.17 
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Table ·7: ANCOV A calculations for HR related cofactors on PWV values after WBV. Significance was set at p:S0.05. 
BaselineHR AHR after WBV 
p value p value 
Aorta 0.30 0.49 
Leg 0.40 0.59 
Arm 0.60 0.69 
Table 8: ANCOVA calculations for MAP related factors. Significance was set at p:::;0.05. 
Baseline MAP AMAP after WBV 
p value p value 
Aorta 0.17 0.49 
Le~ 0.90 0.67 
Arm 0.38 0.40 
~ bl 9 ANCOV A I 1 f £ h . HP d MAP co-factored simultaneously. Significance was set at p:::;0.05. a e : ca cu a 10ns or c anges In an 
AHR and AMAP after WBV 
I! value 
Aorta 0.37 
Leg 0.76 
Arm 0.23 
Table 10: Pearson's r correlation for age, TPI, height and weight and changes in PWV after WBV for all blood vessels 
measured. Significance was set at p<0.05. 
-
Age TPI Height Weight 
r value p value rvalue p value r value p value r value p value 
Aorta ilPWV -0.44 0.91 0.67 0.06 0.35 0.38 0.08 0.83 
Leg ilPWV -0.43 0.28 -0.26 0.52 -0.38 0.92 -0.13 0.74 
Arm ilPWV 0.39 0.33 -0.15 0.70 0.25 0.54 -0.12 0.76 
Table 11: Pearson's r correlation for HR and MAP cofactors and changes in PWV after PS and WBV for all blood vessels 
d S' 'fi t <005 measure. Igm: cance was set a p: 
Baseline HR ~HRwithWBV Baseline MAP ~MAPwith 
WBV 
r value p value r value p value r value p value r value p value 
Aorta ilPWV 0.24 0.55 -0.39 0.33 -0.11 0.79 -0.27 0.50 
Leg ilPWV 0.28 0.49 0.07 0.86 -0.31 0.44 0.37 0.36 
Arm ilPWV -0.54 0.16 -0.23 0.57 0.10 0.80 -0.24 0.56 
~ bl 12 R It f h 2 a e esu sot e -wayan d1 -way ANOVA £ s or eac h d *d vesse measure . . 'fi t change (p<0.05). eno es SIgnI can 
2-way ANOVA I-way ANOVA 
P value PS WBV 
(p-value; ES) (p-value; ES) 
Aorta 0.64 0.731; 0.11 0.117; 0.12 
Leg 0.801 0.047*; -0.39 0.111; -0.27 
Arm 0.918 0.206; -0.19 0.279; -0.25 
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Table J3: Results of the 2-way ANOVA comparing pre- and post- PWV values for the severity and level of injury groups. 
Significance was set at p<0.05. ** denotes trend (0.05<p<0.10) 
Severity Level 
Complete Incomplete Above T5 Below T5 
2-way ANOVA 2-way ANOVA 2-way ANOVA 2-way ANOVA 
(PSvsWBV) (PSvsWBV) (PSvsWBV) (PSvs WBV) 
p value ~ value p value pvalue 
Aorta 0.669 0.936 0.165 0.138 
LeK 0.665 0.204 0.502 0.061 ** 
Arm 0.911 0.207 0.971 0.913 
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Appendix E: Visual Representations of the Apparatus 
Figure 29: Picture of the W A VB equipment, platform and standing frame. 
Figure 30: Visual representation of how the participant stood on the vibration platform. 
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